User Image Cart Icon 0 Search Image

Glycyrrhizin

  1. Pseudo-aldosteronism induced by intravenous Glycyrrhizin treatment of chronic hepatitis C patients
  2. … -performance liquid chromatographic determination of puerarin, daidzin, paeoniflorin, liquiritin, cinnamic acid, cinnamaldehyde and Glycyrrhizin in Kampo medicines
  3. … . ex DC. containing high concentrations of Glycyrrhizin by Eastern blotting and enzyme-linked immunosorbent assay using anti-Glycyrrhizin monoclonal antibody for …
  4. … after Total Adrenalectomy: II. Levels of 17-Ketosteroids and Formaldehy-Dogenic Substances in Patients on Varying Dosages of Cortisone Acetate and Glycyrrhizin
  5. … box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model and Parkinson’s disease which can be attenuated by Glycyrrhizin
  6. … C virus (CH-C) in India: a randomized controlled trial comparing daily interferon-alfa-2b and ribavirin with daily interferon-alfa-2b and Glycyrrhizin—a multicenter study
  7. … crude drugs. IV. Quantitative analysis of constituents in the crude drugs by rod-thin-layer chromatography with FID.(1). Determination of Glycyrrhizin in liquorice roots …
  8. … effects, immune regulatory actions, and inhibition of hepatic apoptosis, necrosis and antitumor effects [17]. In addition, Glycyrrhizin and 18β-glycyrrhetinic acid …
  9. … MULTICOMPONENT MEDICAL COMPOSITION WITH IMMUNOSTIMULATIVE AND ANTIOXIDANT ACTIVITIES (Glycyrrhizin ACID, KHITOZAN, ZEOLITE …
  10. … natural population accessions of Glycyrrhiza glabra L.(Fabaceae) in central Zagros region of Iran, based on quantitative morphology, flavonoids and Glycyrrhizin …
  11. … natural population accessions of Glycyrrhiza glabra L.(Fabaceae) in central Zagros region of Iran, based on quantitative morphology, flavonoids and Glycyrrhizin …
  12. … notably the 3-O-glycosides abrusosides A–D (C6| C6| C6| C5CH (CH) C5L 3-O-glycosides) from Abrus species (Fabaceae) and Glycyrrhizin (glycyrrhizic acid) from …
  13. … of double eastern blotting for major licorice components, Glycyrrhizin and liquiritin for chemical quality control of licorice using anti-Glycyrrhizin and anti-liquiritin …
  14. … of Glycyrrhizin and liquiritin in licorice roots and Kampo medicines by combination enzyme-linked immunosorbent assay using anti-Glycyrrhizin and anti-liquiritin …
  15. … of Glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing Glycyrrhizin and related compounds
  16. … on effects of Achyranthes bidentata on tongsaimai pellets main active ingredients chlorogenic acid, isoliquiritin, harpagoside and Glycyrrhizin in vivo pharmacokinetics
  17. … on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of Glycyrrhizin
  18. … on the pharmaceutical quality evaluation of crude drug preparations used in orient medicine” kampoo”. Iii. Precipitation reaction of Glycyrrhizin with alkaloids or …
  19. … on the pharmaceutical quality evaluation of crude drug preparations used in orient medicine” Kampoo”. III. Precipitation reaction of Glycyrrhizin with alkaloids or …
  20. … profiles of acetaminophen and its glucuronide after pretreatment with combinations of N-acetylcysteine and either Glycyrrhizin, silibinin or spironolactone in rat
  21. … Quality Evaluation of Crude Drug Preparations used in Orient Medicine” Kampoo”. II. Precipitation Reaction of Berberine and Glycyrrhizin in Aqueous Solution
  22. … quality evaluation of crude drug preparations used in orient medicine” kampoo”. II. Precipitation reaction of berberine and Glycyrrhizin in aqueous solution.
  23. … Reaction between Berberine and Glycyrrhizin in Decoctions of Natural Medicines: Interaction Studies of Cyclodextrins with Glycyrrhizin and Glycyrrhetic Acid by 1H …
  24. … ribosomal P proteins from porcine liver and the inhibition of their immunocomplex formation with sera from systemic lupus erythematosus (SLE) patients by Glycyrrhizin …
  25. 18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells
  26. 52weeks clinical observation of combination therapy of telbivudine with compound Glycyrrhizin tables on chronic hepatitis B
  27. A 96-KDa Glycyrrhizin-binding protein (gp96) from soybeans acts as a substrate for case in kinase II, and is highly realted to lipoxygenase3
  28. A case of Glycyrrhizin (licorice)-induced hypokalemic myopathy
  29. A case of pseudoaldosteronism induced by Glycyrrhizin
  30. A Case of Pseudoaldosteronism with Muscle Weakness due to Oral Glycyrrhizin
  31. A clinical observation of compound Glycyrrhizin injection in treatment of 40 children with henoch-schonlein purpura
  32. A clinical study on treatment of chromic hepatitis B with acute exacerbation by Compound Glycyrrhizin Injection [J]
  33. A comparative study of Glycyrrhizin and glycyrrhetinic acid complexes interactions with DNA and RNA
  34. A comparison of the antihepatotoxic activity between Glycyrrhizin and glycyrrhetinic acid
  35. A Comprison of Cost-effectiveness Between Compound Glycyrrhizin and Interferon α-1b in Treating Chronic Hepatitis B
  36. A discovery of Glycyrrhizin synthase in a medical plant, liquorice [Glycyrrhiza uralensis].
  37. A first report of porphyria cutanea tarda successfully treated with Glycyrrhizin
  38. A Glycyrrhizin‐containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice
  39. A high performance liquid chromatography method for the simultaneous determination of arctiin, chlorogenic acid and Glycyrrhizin in a Chinese proprietary medicine
  40. A highly sensitive LC–MS/MS method for simultaneous determination of Glycyrrhizin and its active metabolite glycyrrhetinic acid: Application to a human …
  41. A long-term Glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of …
  42. A Membrane-Based Process for the Recovery of Glycyrrhizin and Phenolic Compounds from Licorice Wastewaters
  43. A new anti-human immunodeficiency virus substance, Glycyrrhizin sulfate; endowment of Glycyrrhizin with reverse transcriptase-inhibitory activity by chemical …
  44. A novel glucuronosyltransferase has an unprecedented ability to catalyse continuous two‐step glucuronosylation of glycyrrhetinic acid to yield Glycyrrhizin
  45. A novel preparation of concentrated Glycyrrhizin solution by pretreatment with eugenol
  46. A novel serum-stable liver targeted cytotoxic system using valerate-conjugated chitosan nanoparticles surface decorated with Glycyrrhizin
  47. A novel β-glucuronidase from Talaromyces pinophilus Li-93 precisely hydrolyzes Glycyrrhizin into glycyrrhetinic acid 3-O-mono-β-d-glucuronide
  48. A pilot study of oral tranexamic acid and Glycyrrhizin compound in the treatment of recalcitrant Riehl’s melanosis
  49. A possible involvement of 3-monoglucuronyl-glycyrrhetinic acid, a metabolite of Glycyrrhizin (GL), in GL-induced pseudoaldosteronism
  50. A randomized controlled trial comparing total glucosides of paeony capsule and compound Glycyrrhizin tablet for alopecia areata
  51. A randomized controlled trial of Glycyrrhizin plus tenofovir vs. tenofovir in chronic hepatitis B with severe acute exacerbation
  52. A Research on Seasonal Dynamics of Biomass of Glycyrrhizin Uralensis Seedings in Western Part of Jilin Province [J]
  53. A Review on the Role of Nutraceuticals as Simple as Se2+ to Complex Organic Molecules Such as Glycyrrhizin That Prevent as Well as Cure Diseases
  54. A semi-physiologically based pharmacokinetic pharmacodynamic model for Glycyrrhizin-induced pseudoaldosteronism and prediction of the dose limit …
  55. A simple preparation method for dispersing Glycyrrhizin solution into oil phase using an evaporation technique
  56. A Simple Semi‐preparative Reversed‐phase HPLC/PDA Method for Separation and Quantification of Glycyrrhizin in Nine Samples of Glycyrrhiza glabra Root …
  57. A study on the pharmacetical characteristics & analysis of Glycyrrhizin extract
  58. A Study to Investigate the Cytotoxic role of Glycyrrhizin A Triterpenoid Glycoside from Glycyrrhiza Glabra in Cervical Cancer
  59. A systematic review of quality of randomized controlled trials of Glycyrrhizin acid to treat hepatitis in China
  60. Absorption-enhancing effect of Glycyrrhizin induced in the presence of capric acid
  61. Acetyl glycyrrhetinic acid methyl ester as a promising Glycyrrhizin derivative against the breast cancer cells (MCF-7)
  62. Administration-route dependency of absorption of Glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability
  63. Adsorption separation of 3β-D-monoglucuronyl-18βglycyrrhetinic acid from directional biotransformation products of Glycyrrhizin
  64. Advances in studies on Glycyrrhizin [J]
  65. Affection of Glycyrrhizin on Expression of CCL20 in HepG2. 2. 15 Cells [J]
  66. Agrobacterium rhizogenes induced hairy root development and its effect on production of Glycyrrhizin in Abrus precatorius (L)
  67. Alleviation of salt stress and changes in Glycyrrhizin accumulation by arbuscular mycorrhiza in liquorice (Glycyrrhiza glabra) grown under salinity stress
  68. Ameliorative effects of Glycyrrhizin on streptozotocin‐induced diabetes in rats
  69. AMMONIACAL COMPOUND OF Glycyrrhizin.
  70. Ammonium Glycyrrhizin counteracts liver injury caused by lipopolysaccharide/amoxicillin-clavulanate potassium
  71. An antigranulomatous effect of Glycyrrhizin
  72. An antigranulomatous effect of Glycyrrhizin.
  73. An Approach to Treatment of Liver Cancer by Novel Glycyrrhizin Derivative
  74. An Artificial Sweetener Stimulates the Sweet Taste in Insect: Dual Effects of Glycyrrhizin in Phormia regina
  75. An experimental studies on the growth inhibition and its action of a salivary gland tumor by Glycyrrhizin
  76. An inhibitory effect of Glycyrrhizin on metabolic actions of cortisone
  77. An Observation on Curative Effects of Compound Glycyrrhizin in the Treatment of Chronic Type B Hepatitis with Hepatic Fibrosis
  78. An on-membrane quantitative analysis system for Glycyrrhizin in licorice roots and traditional Chinese medicines
  79. AN OVERVIEW ON THE EXTRACTION, SEPARATION, AND APPLICATIONS OF Glycyrrhizin AND GLYCYRRHETIN [J]
  80. Analysis of broad-sense heritability and genetic correlation of production and content of Glycyrrhizin of annual Glycyrrhiza uralensis
  81. Analysis of Clinical Effects of Compound Glycyrrhizin and Levocetirizine on Treating Chronic Eczema
  82. Analysis of clinical effects of Compound Glycyrrhizin on treatment of 53 cases of psoriasis vulgaris.
  83. Analysis of content differences and variation trends of the principal component isomers and related substances in the four generations of Glycyrrhizin preparations
  84. Analysis of the Chest X-ray Manifestations in SARS Patients Treated with Compound Glycyrrhizin
  85. Analysis of the Chest X-ray Manifestations in SARS Patients Treated with Compound Glycyrrhizin [J]
  86. Analysis of the synergistic effect of Glycyrrhizin and other constituents in licorice extract on lipopolysaccharide-induced nitric oxide production using knock-out extract
  87. Analysis of therapeutic efficacy of the combination of 308 nm excimer laser with compound Glycyrrhizin for treatment of vitiligo
  88. Anaphylactic shock and ventricular extrasystole following an IV infusion of compound Glycyrrhizin in a patient with allergic dermatitis [J]
  89. Anti-inflammative effect of Glycyrrhizin on rat thermal injury via inhibition of high-mobility group box 1 protein
  90. Anti-inflammatory effects of intramammary infusions of Glycyrrhizin in lactating cows with mastitis caused by coagulase-negative staphylococci
  91. Anti-liver Fibrosis Effect of Ganlong Capsule Combined with Compound Glycyrrhizin Glucoside
  92. Anti-obesity effect of Chitosan-Glycyrrhizin conjugate
  93. Anti-obesity effect of Glycyrrhizin on obese rats and its mechanism [J]
  94. Anti-Proliferative and Differentiation-Inducing Effects of Glycyrrhizin and 18p-Glycyrrhetinic Acid on Neuroblastoma Cells In Vitro
  95. Anti-tumor Activity of Adriamycin-loaded Chitosan Nanoparticles Surface-modified with Glycyrrhizin on Human Hepatoma Cell Line SMMC-7721
  96. Antidiabetic effect of Glycyrrhizin in genetically diabetic KK-Ay mice
  97. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, Glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction
  98. Antifibrotic effects of Glycyrrhizin and matrine in vitro and in vivo
  99. Antifibrotic Effects of High-Mobility Group Box 1 Protein Inhibitor (Glycyrrhizin) on Keloid Fibroblasts and Keloid Spheroids through Reduction of Autophagy …
  100. Antihyperglycemic effect of 18β-glycyrrhetinic acid, aglycone of Glycyrrhizin, on streptozotocin-diabetic rats
  101. Antioxidant activities of Glycyrrhizin and its effect on renal expression of Na, K-ATPase in gentamicin-induced acute renal failure rats
  102. Antioxidant and DNA protective effects of NTX, a proprietary Glycyrrhizin/d-mannitol product, in association with alcohol consumption: A randomized, placebo …
  103. Antioxidant status and immune activity of Glycyrrhizin in allergic rhinitis mice
  104. ANTISTRESS POTENTIAL OF Glycyrrhizin IN FORCED SWIM STRESS
  105. Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor
  106. Antiviral activities of Glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro
  107. Antiviral activities of Glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro.
  108. Antiviral activity of Glycyrrhizin against hepatitis C virus in vitro
  109. Antiviral activity of Glycyrrhizin against varicella-zoster virus in vitro
  110. Antiviral and immune stimulant activities of Glycyrrhizin against duck hepatitis virus
  111. Antiviral Effect of Glycyrrhizin on Porcine Respiratory Coronavirus (PRCV).
  112. Antiviral effects of the combination of Glycyrrhizin and ribavirin against influenza a H1N1 virus infection in vivo
  113. Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and Glycyrrhizin-mediated inhibition
  114. Application of an amine functionalized biopolymer in the colonic delivery of Glycyrrhizin: a design and in vivo efficacy study
  115. Application of Glycyrrhizin in the preparation of medicine for preventing and curing tumour
  116. Application of ion-pair high-performance liquid chromatography to the analysis of Glycyrrhizin in Glycyrrhizae radix
  117. Application of liquid particle extraction to the purification of Glycyrrhizin
  118. Application of pressure‐controlled colon delivery capsule to oral administration of Glycyrrhizin in dogs
  119. Approach to enhancing the distribution of Glycyrrhizin in the liver: intravenous infusion studies in a rat model of bile duct ligation
  120. Arabinogalactan and Glycyrrhizin based nanopesticides as novel delivery systems for plant protection
  121. Arbuscular mycorrhiza facilitates the accumulation of Glycyrrhizin and liquiritin in Glycyrrhiza uralensis under drought stress
  122. Assessment of circulating biochemical markers in mice receiving cinnamon and Glycyrrhizin under carbon tetrachloride induced hepatic injury
  123. Assessment of the tolerability profile of an ophthalmic solution of 5% Glycyrrhizin and copolymer PEG/PPG on healthy volunteers and evaluation of its efficacy …
  124. Attenuation of dysfunction in the ischemia-reperfused liver by Glycyrrhizin
  125. Augmented antiproliferative effect of tumor necrosis factor (TNF), lymphotoxin and Glycyrrhizin in combined use with diethyldithiocarbamate on Meth A tumor cells in …
  126. Bidirectional control by Glycyrrhizin of the growth response of lymphocytes stimulated through a receptor-bypassed pathway
  127. Biliary excretion and enterohepatic cycling of Glycyrrhizin in rats
  128. Biliary excretion of Glycyrrhizin in rats: kinetic basis for multiplicity in bile canalicular transport of organic anions
  129. Bimodal effect of Glycyrrhizin on macrophage nitric oxide and prostaglandin E2 production
  130. Binding of Glycyrrhizin to human serum and human serum albumin
  131. Binding of Glycyrrhizin to rat plasma and rat serum albumin
  132. Bioavailability of Glycyrrhizin and licorice extract in rat and human plasma as detected by a HPLC method.
  133. Bioavailability of Glycyrrhizin from Shaoyao‐Gancao‐Tang in laxative‐treated rats
  134. Bioavailability study of glycyrrhetic acid after oral administration of Glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis
  135. Biocatalytic properties of a novel crude Glycyrrhizin hydrolase from the liver of the domestic duck
  136. Biochemical and histological effects of 26 weeks of Glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial
  137. Biochemical characterization of bovine lactoferrin as a Glycyrrhizin-binding protein in vitro
  138. Biochemical characterization of Glycyrrhizin as an effective inhibitor for hyaluronidases from bovine testis
  139. Biochemical characterization of recombinant HIV-1 reverse transcriptase (rRT) as a Glycyrrhizin-binding protein and the CK-II-mediated stimulation of rRT activity …
  140. Biochemical characterization of selective inhibitors for a Glycyrrhizin-binding lipoxygenase from soybeans
  141. Bioequivalence of domestic and imported compound Glycyrrhizin tablets in Chinese healthy male volunteers
  142. Bioequivalence of Glycyrrhizin capsules by HPLC-MS [J]
  143. Bioequivalence research of Compound Glycyrrhizin capsules
  144. Bioinformatics Study and Investigation of the Expression Pattern of Several Important Genes Involved in Glycyrrhizin Synthesis of Glycyrrhiza glabra L. in Autumn and …
  145. Biotechnological aspects of the production of natural sweetener Glycyrrhizin from Glycyrrhiza sp.
  146. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, Glycyrrhizin, and baicalin by human fecal …
  147. Biotransformation of Glycyrrhizin by Aspergillus niger
  148. Biotransformation of Glycyrrhizin by buffered cell suspension cultures of Catharanthus roseus
  149. Biotransformation of Glycyrrhizin by Buffered Cell Suspension Cultures of Catharanthus roseus.
  150. Biotransformation of Glycyrrhizin by human intestinal bacteria and its relation to biological activities
  151. Biotransformation of Glycyrrhizin to 18β-glycyrrhetinic acid-3-O-β-D-glucuronide by Streptococcus LJ-22, a human intestinal bacterium
  152. Blocking effects of blended paeoniflorin or its related compounds with Glycyrrhizin on neuromuscular junctions in frog and mouse
  153. Butyl Flufenamate Ointment and Abcompound Glycyrrhizin Tabletin the Treatment of Postherpetic Neuralgia
  154. Can active components of licorice, Glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis?
  155. Candesartan and Glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade
  156. CD34+ CD31+ immature myeloid cells (IMC) as an inhibitor cell on the production of antimicrobial peptide: III. Translational studies of Glycyrrhizin in humanized NOD …
  157. Changes in components, Glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis Fisch, modify insulin sensitizing and insulinotropic actions
  158. Changes in Glycyrrhizin content of Iranian licorice (Glycyrrhiza glabra L.) affected by different root diameter and ecological conditions
  159. Characteristics and molecular determinants of a highly selective and efficient Glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10
  160. Characteristics of intestinal absorption and disposition of Glycyrrhizin in mice
  161. Characterization of an apoptosis-inducing factor in Habu snake venom as a Glycyrrhizin (GL)-binding protein potently inhibited by GL in vitro
  162. Characterization of bovine and human lactoferrins as Glycyrrhizin-binding proteins and their phosphorylation in vitro by casein kinase II
  163. Characterization of bovine angiogenin-1 and lactogenin-like protein as Glycyrrhizin-binding proteins and their in vitro phosphorylation by C-kinase
  164. Characterization of complement C3 as a Glycyrrhizin (GL)-binding protein and the phosphorylation of C3α by CK-2, which is potently inhibited by GL and glycyrrhetinic …
  165. Characterization of Glycyrrhizin-binding protein kinase from the crude membrane fraction of rat liver
  166. Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a Glycyrrhizin (GL)-binding protein and the GL-induced inhibition of the CK-II-mediated …
  167. Characterization of the interaction of Glycyrrhizin and glycyrrhetinic acid with bovine serum albumin by spectrophotometric-gradient flow injection titration technique …
  168. Characterization of three ocular clinical isolates of P. aeruginosa: viability, biofilm formation, adherence, infectivity, and effects of Glycyrrhizin
  169. Chemical assay of Glycyrrhizin in medicinal plants by pressurized liquid extraction (PLE) with capillary zone electrophoresis (CZE)
  170. Chemopreventive activity of Glycyrrhizin on lead acetate mediated hepatic oxidative stress and its hyperproliferative activity in Wistar rats
  171. Chronic effects of ginseng saponin, Glycyrrhizin and flavin adenine dinucleotide on adrenal and thymus weight in normal and dexamethasone-treated rats
  172. Cilostazol/Glycyrrhizin interaction
  173. Clinic Observation on Compound Glycyrrhizin Injection Treatment for Children with Henoch-Schonlein Purpura [J]
  174. Clinical Analysis of Compound Glycyrrhizin Injection Combined with Acitretin in the Treatment of Erythrodermic Psoriasis [J]
  175. Clinical analysis of compound Glycyrrhizin tablets combined with tretinoin cream and mometasone furoate cream in treating psoriasis vulgaris
  176. Clinical analysis of the function of Salvia Miltiorrhiza combined with Comp-ound Glycyrrhizin Injection (Stronger Neo-Minophagen C) in the treatment of alcoholic liver …
  177. Clinical Analysis of Treatment on Generalized Pustular Psoriasis through Compound Glycyrrhizin in Combination with Acitretin
  178. Clinical and experimental study on treatment of atopic dermatitis with Glycyrrhizin
  179. CLINICAL AND LABORATORY OBSERVATION ON THE EFFECT OF Glycyrrhizin IN ACUTE AND CHRONIC VIRAL HEPATITIS
  180. Clinical Application of Compound Glycyrrhizin Glucoside in Dermatology (Review)[J]
  181. Clinical Application of Compound Glycyrrhizin Glucoside in Dermatology [J]
  182. Clinical Application of Glycyrrhizin and Its Pharmacological Effect
  183. Clinical characteristics of five elderly patients with severe hypokalemia induced by Glycyrrhizin derivatives
  184. Clinical effect comparison between compound Glycyrrhizin injection and diammonium Glycyrrhizinate injection in treatment of extensive eczema
  185. Clinical Effect Observation of Compound Glycyrrhizin Combined Tripterygium Glycosides in Treatment of Palmoplantar Pustulosis [J]
  186. Clinical effect observation of compound Glycyrrhizin on the prevention and cure of cytarabine syndromes
  187. Clinical Effect of Compound Glycyrrhizin Injection in Treatment of Acute Urticaria
  188. Clinical Effect of Mizolastine Combined with Compound Glycyrrhizin Capsules in the Treatment of Chronic Urticaria
  189. Clinical effects of compound Glycyrrhizin combined with glutathione for 60 cases with alcoholic liver disease [J]
  190. Clinical Effects of Compound Glycyrrhizin Injection, Tacrolimus Ointment, Avene on Facial Corticosteroid Addictive Dermatitis [J]
  191. Clinical efficacy and IgE levels of ebastine joint Compound Glycyrrhizin on acute and chronic urti-caria patients
  192. Clinical Efficacy Observation of Compound Glycyrrhizin Combined with Triamcinolone Acetonide in the Treatment of Oral Lichen Planus
  193. Clinical efficacy of combination of vidarabine monophosphate with compound Glycyrrhizin in treatment of herpes zoster.
  194. CLINICAL EFFICACY OF COMPOUND Glycyrrhizin COMBINED WITH ACITRETIN FOR GENERALIZED PUSTULAR PSORIASIS [J]
  195. Clinical Efficacy of Compound Glycyrrhizin Combined with Famciclovir for Herpes Zoster [J]
  196. Clinical Efficacy of Compound Glycyrrhizin Combined with Reduced Glutathione on Patients with Alcoholic Liver Cirrhosis [J]
  197. Clinical Efficacy of Epinastine in Combination with Compound Glycyrrhizin for Chronic Eczema [J]
  198. Clinical efficacy study of polyene phosphatidylcholine combined with compound Glycyrrhizin in treatment of non-alcoholic fatty liver
  199. Clinical evaluation of compound Glycyrrhizin for treatment of antituberculous drug-induced liver disease [J]
  200. Clinical investigation of compound Glycyrrhizin combined with bozhi glycopeptide in treatment of erythema nodosum
  201. Clinical Investigation of Compound Glycyrrhizin with Adefovir Dipivoxil in the treatment of Hepatic Fibrosis of Chronic Hepatitis B
  202. Clinical Investigation on Glycyrrhizin Compound with Rifampicin and Doxycycline in Treating Brucellosis
  203. Clinical Investigation on the Efficacy of Facial Mask Combined Triclosan with Glycyrrhizin for Acne Vulgaris
  204. Clinical observation and pharmacoeconomic evaluation on compound Glycyrrhizin in the treatment of psoriasis vulgaris [J]
  205. Clinical observation of Compound Glycyrrhizin and Oxymatrine in the treatment of 52 cases with chronic hepatitis B
  206. Clinical Observation of Compound Glycyrrhizin Combination with Acyclovir in the Treatment of Children with Infectious Mononucleosis
  207. Clinical Observation of Compound Glycyrrhizin Combining Flumetasone in the Treatment of Chronic Eczema [J]
  208. Clinical observation of compound Glycyrrhizin for Non-Alcoholic steatohepatitis
  209. Clinical Observation of Compound Glycyrrhizin Injection on Treatment of Pollinosis
  210. Clinical observation of compound Glycyrrhizin on chronic hepatitis B [J]
  211. Clinical observation of compound Glycyrrhizin on hepatic fibrosis of chronic hepatitis B [J]
  212. Clinical Observation of Glycyrrhizin Decremental Treatment Combined with Ebastine for Chronic Urticaria [J]
  213. Clinical Observation of Runzaozhiyang Capsules Combined with Compound Glycyrrhizin in the Treatment of Xiexvfengzao Eczema
  214. CLINICAL OBSERVATION OF THE EFFICACY OF Glycyrrhizin IN THE TREATMENT OF NEWBORNS WITH HYPERBILIRUBINAEMIA [J]
  215. Clinical Observation of Therapeutic Effect of Compound Glycyrrhizin on SARS
  216. Clinical Observation of Therapeutic Effect of Compound Glycyrrhizin on SARS [J]
  217. Clinical Observation on Compound Glycyrrhizin Combined with Interferon α-2b in the Treatment of Chronic Hepatitis B
  218. Clinical Observation on Compound Glycyrrhizin Combined with Interferon?-2b in the Treatment of Chronic Hepatitis B
  219. Clinical observation on compound Glycyrrhizin combined with narrow-band UVB in treatment ofpsoriasis vulgaris [J]
  220. Clinical Observation on Compound Glycyrrhizin in Combination with Acyclovir for Herpes Zoster [J]
  221. Clinical Observation on Compound Glycyrrhizin Injection Combined with Alprostadil Injection for Severe Cholestatic Virus Hepatitis [J]
  222. Clinical Observation on Glycyrrhizin Anhydride in the Treatment of Drug-induced Liver Damage
  223. Clinical Observation on the Clinical Efficacy of Compound Glycyrrhizin in the Antitubercuolsis Treatment of Chronic Hepatitis B [J]
  224. Clinical observation on the clinical efficacy of compound Glycyrrhizin in the treatment of new pulmonary tuberculosis complicated with chronic hepatitis B
  225. Clinical observation on the clinical efficacy of Compound Glycyrrhizin in the treatment of tuberculosis with retreated and chronic hepatitis B (Analysis of 56 cases)
  226. Clinical Observation on Therapeutic Effect of Compound Glycyrrhizin for Facial Hormone Dependence Dermatitis [J]
  227. Clinical observation on treatment of primary Sjögren’s syndrome by compound Glycyrrhizin injection
  228. Clinical observations and influence on NO of compound Glycyrrhizin on cirrhotic patients following chronic hepatitis B
  229. Clinical Research of Compound Glycyrrhizin Combined with Large Dose Hepatocyte Growth-promoting Factors in the Treatment of Severe Hepatitis [J]
  230. Clinical Research of Compound Glycyrrhizin Combined with Levofloxacin and Doxycycline in the Treatment of Chronic Brucellosis
  231. Clinical Research of Entecavir Combined with Compound Glycyrrhizin Tablets on Chronic Hepatitis B with HBeAg-Positive [J]
  232. Clinical spectrum of acute sporadic hepatitis E and possible benefit of Glycyrrhizin therapy
  233. Clinical study of Glycyrrhizin in combination with lamivudine for treatment of HBV-related nephritis
  234. Clinical Study of Hyperbaric Oxygen Combined with Compound Glycyrrhizin in the Treatment of Psoriasis Vulgaris
  235. Clinical study of PHGF combined with compound Glycyrrhizin on patients with severe hepatitis
  236. Clinical Study on the Prevention of Glycyrrhizin on the Hepatitis Resulted from Antituberculous Drugs [J]
  237. Clinical study on treatment of severe viral hepatitis by Compound Glycyrrhizin Injection [J]
  238. Clinical Therapeutic Observation of Man’gan Decoction Plus Compound Glycyrrhizin in the Treatment of Chronic Type B Hepatitis
  239. Clinical trial of compound Glycyrrhizin injection for the treatment of radiation-induced liver disease [J]
  240. Cloning and characterization of a cDNA encoding β-amyrin synthase involved in Glycyrrhizin and soyasaponin biosyntheses in licorice
  241. Clostridium Glycyrrhizinilyticum Sp. Nov., a Glycyrrhizin‐Hydrolysing Bacterium Isolated from Human Faeces
  242. Clove oil prevents Glycyrrhizin gel formation in aqueous solution
  243. Co-delivery of Glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for …
  244. COLORIMETRIC DETERMINATION OF Glycyrrhizin CONTENT IN THE CRUDE AND HONEY-PROCESSED GLYCYRRHIZA WITH VANILLIN-SULPHURIC ACID …
  245. Colorimetric Estimation of Glycyrrhizin Content in Glycyrrhizainflata Produced in Four Provinces [J]
  246. Combination of Spirulina with Glycyrrhizin prevents cognitive dysfunction in aged obese rats
  247. Combination therapy of Glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B.
  248. Combination therapy of orally administered Glycyrrhizin and UVB improved active-stage generalized vitiligo
  249. Combination therapy with salicylic acid chemical peels, Glycyrrhizin compound, and vitamin C for Riehl’s melanosis
  250. Combined ursodeoxycholic acid and Glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.
  251. Combining compound Glycyrrhizin with hepatocyte growth-promoting factors for treatment of hepatic fibrosis [J]
  252. Comparative analysis of the effect of Glycyrrhizin diammonium and lithium chloride on infectious bronchitis virus infection in vitro
  253. Comparative Studies of Different Immobilization Techniques for Conversion of Glycyrrhizin by Aspergillus niger NRRL 595
  254. Comparative study for pharmaceutical quality among bland-name drug and generic drugs of compound Glycyrrhizin injections in China
  255. Comparative study of selective in vitro and in silico BACE1 inhibitory potential of Glycyrrhizin together with its metabolites, 18α-and 18β-glycyrrhetinic acid, isolated …
  256. COMPARING STUDIES ON THE COMPONENTS OF Glycyrrhizin IN FIVE KINDS OF GLYCYRRHIZA UNDER THE SAME CONDITIONS [J]
  257. COMPARING STUDIES ON THE COMPONENTS Or Glycyrrhizin IN FIVE KINDS OF GLYCYRRHIZA UNDER THE SAME CONDITIONS
  258. Comparison of clinical efficacy and safety of triclosan lasatopine combined with compound Glycyrrhizin tablets in the treatment of chronic urticaria
  259. Comparison of Efficacies of Acyclovir with Glycyrrhizin Against Herpes Simple Virus Type 1 in Vitro
  260. Comparison of Glycyrrhizin content in 25 major kinds of Kampo extracts containing Glycyrrhizae Radix used clinically in Japan
  261. Comparison of Glycyrrhizin Contents in Granule of Dispensing Glycyrrhizae from Different Factories [J]
  262. Comparison of Particulate Contamination in Glass and Plastic Ampoules of Glycyrrhizin Injections after Ampoule Cutting.
  263. Comparison of protective effect of Glycyrrhizin drugs on human hepatocytes injured by D-galactosamine and carbon tetrachloride
  264. Comparison of the Exposure of Glycyrrhizin and its Metabolites and the Pseudoaldosteronism after Intravenous Administration of Alpha-and Beta-Glycyrrhizin in Rat
  265. Comparison of the in vitro antifibrogenic effects of silymarin, silybin a and 18α-Glycyrrhizin on activated hepatic stellate cells
  266. Comparison of Therapeutic Effects of Compound Glycyrrhizin Injection at Different Doses on Severe Hepatitis
  267. Competition in the metabolism of Glycyrrhizin with glycyrrhetic acid mono-glucuronide by mixed Eubacterium sp. GLH and Ruminococcus sp. PO1-3
  268. Complementary Effects of Paeoniflorin and Glycyrrhizin on Intracellular Call Mobilization in the Nerve-Stimulated Skeletal Muscle of Mice
  269. Compound ammonium Glycyrrhizin protects hepatocytes from injury induced by lipopolysaccharide/florfenicol through a mitochondrial pathway
  270. Compound ammonium Glycyrrhizin protects hepatocytes from injury induced by lipopolysaccharide/florfenicol through oxidative stress and a MAPK pathway
  271. Compound Flumetasone Ointment Combined with Compound Glycyrrhizin Tablets in the Treatment of Infant Eczyma in 45 Cases
  272. Compound Glycyrrhizin and Interferon in the Treatment of Chronic Hepatitis B Study [J]
  273. Compound Glycyrrhizin associated with ARA-AMP in treating chronic hepatitis B patients with YMDD Mutation
  274. Compound Glycyrrhizin Combination with Matrine Treatment for Chronic Hepatitis B
  275. Compound Glycyrrhizin Combined Montelukast Treatment of Cough Variant Asthma
  276. Compound Glycyrrhizin Combined Ornithine Aspartate Treatment of Severe Hepatitis
  277. Compound Glycyrrhizin Combined with Cetirizine in Improving the Life of Quality Patients with Chronic Urticaria [J]
  278. Compound Glycyrrhizin Combined with Mizolastine for Patients with Generalized Neurodermatitis: Observation of Curative Effects and the Influence on Psychological …
  279. Compound Glycyrrhizin Combined with Narrow Band Ultraviolet B in Treatment of Pityriasis Rosea Curative Effect
  280. Compound Glycyrrhizin for alcoholic hepatitis: observation of clinical efficacy
  281. Compound Glycyrrhizin for Chronic Hepatitis B Complicating Severe Jaundice and Hepatic Fibrosis: Observation of Clinical Efficacy [J]
  282. Compound Glycyrrhizin for Hepatic Cirrhosis Caused by Hepatitis B: Observation of Curative Efficacy [J]
  283. Compound Glycyrrhizin for Hepatic Lesion Induced by Antituberculosis Drugs: Observation of 30 Cases [J]
  284. Compound Glycyrrhizin for Pregnant Women Complicating Chronic Type B Hepatitis: Observation of Curative Effect [J]
  285. Compound Glycyrrhizin for Psoriasis Vulgaris: Observation of Curative Effects
  286. Compound Glycyrrhizin in the Prevention of Liver Injury Induced by Antituberculosis Drugs
  287. Compound Glycyrrhizin Injection treatment of children with acute jaundice hepatitis clinical observation of 35 cases
  288. Compound Glycyrrhizin Oxymatrine Joint Observation of the effect of the treatment of alcoholic cirrhosis [J]
  289. Compound Glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials
  290. Compound Glycyrrhizin plus UVB Exposure for Pityriasis Rosea
  291. Compound Glycyrrhizin tablet combined with ribavirin in treatment of eruption like papular acrodermatitis of childhood
  292. Content Determination of Glycyrrhizic Acid in Glycyrrhizin Liposome by RP-HPLC [J]
  293. Content determination of Glycyrrhizin in glycyrrhizae uralensis by dual-wavelength TLC scanning
  294. Content Determination of Paeoniflorin and Glycyrrhizin in Baihegujin Decoction with Reversed-phase High-efficiency Liquid Chromatography [J]
  295. Correction to: Comparison of Glycyrrhizin content in 25 major kinds of Kampo extracts containing Glycyrrhizae Radix used clinically in Japan
  296. Correlation between High Intake of Glycyrrhizin and Myolysis of the Papillary Muscles: An Experimental in vivo Study
  297. Counteracting effect of Glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom
  298. Critical roles of platelets in lipopolysaccharide-induced lethality: effects of Glycyrrhizin and possible strategy for acute respiratory distress syndrome
  299. Cultivation research for high-Glycyrrhizin licorice by applying low temperature and Ca2+ ion as environmental stress based on field investigation
  300. Curative Effect Observation of 30 Cases Alopecia Areata Treated by Compound Glycyrrhizin Combined PUVA [J]
  301. Curative Effect Observation on Chronic Urticaria Treated by Compound Glycyrrhizin Injection
  302. Curative Effect of Steroid-dependent Scrotitis Treated with Tacrolimus Ointment and Combine Glycyrrhizin [J]
  303. Curative Efficacy of Compound Glycyrrhizin Capsules for Chronic Hepatitis C [J]
  304. Cyclic Voltammetric Study of Complexes of Fe (III) with Saponins Isolated from Cicer aritinum and Glycyrrhizin
  305. Decreasing effects by Glycyrrhizin and paeoniflorin on intracellular Ca2+-aequorin luminescence transients with or without caffeine in directly stimulated-diaphragm …
  306. Depolarizing effects of Glycyrrhizin-derivatives relating to the blend effects with paeoniflorin in mouse diaphragm muscle
  307. Depolarizing neuromuscular blocking action induced by electropharmacological coupling in the combined effect of paeoniflorin and Glycyrrhizin
  308. Derivatization, molecular docking and in vitro acetylcholinesterase inhibitory activity of Glycyrrhizin as a selective anti-Alzheimer agent
  309. Desoxycorticosterone-mimetic action of ammoniated Glycyrrhizin in rats
  310. Determination of 18α-Glycyrrhizin and 18β-Glycyrrhizin in dog plasma by high-performance liquid chromatography
  311. Determination of 18β-glycyrrhetinic acid in human urine after ingestion of Glycyrrhizin
  312. Determination of 5-hydroxymethyl-2-furfural, albiflorin, paeoniflorin, liquiritin, ferulic acid, nodakenin, and Glycyrrhizin by HPLC-PDA, and evaluation of the cytotoxicity …
  313. Determination of ammonium glycyrrhenate in compound Glycyrrhizin and sodium chloride injection by HPCE
  314. Determination of ammonium Glycyrrhizinate in compound Glycyrrhizin tablets by HPLC
  315. Determination of chlorogenic acid, Glycyrrhizin and glycyrrhetinic acid in yinqiaojiedupian by high performance capillary electrophoresis
  316. Determination of Chlorogenic Acid, Glycyrrhizin and Glycyrrhetinic Acid in Yinqiaojiedupian by High Performance Capillary Electrophoresis [J]
  317. Determination of cinnamaldehyde, cinnamic acid, paeoniflorin, Glycyrrhizin and [6]-gingerol in the traditional Chinese medicinal preparation Kuei-chih-tang by …
  318. Determination of Compound Glycyrrhizin for injection by HPLC [J]
  319. Determination of content of Glycyrrhizin in single and mixed decoction of Four Noble Ingredients [J]
  320. Determination of Cysteine Hydrochloride and Glycine in Compound Glycyrrhizin for Injection by Precolumn Derivatization HPLC [J]
  321. Determination of dissolution of compound Glycyrrhizin tablets by HPLC
  322. Determination of gentiopicroside, mangiferin, palmatine, berberine, baicalin, wogonin and Glycyrrhizin in the traditional Chinese medicinal preparation Sann …
  323. Determination of Glycine and Cysteine Hydrochloride in Compound Glycyrrhizin Injection by HPLC
  324. Determination of Glycine and Methionine in Compound Glycyrrhizin Capsules by Precolumn Derivatization HPLC [J]
  325. Determination of glycine and methionine in Compound Glycyrrhizin Tablets by HPLC [J]
  326. Determination of Glycyrrhizin Acid in Gan-xin Spray by RP-HPLC
  327. Determination of Glycyrrhizin and 18 alpha-, 18 beta-glycyrrhetinic acid in rat plasma by high-performance thin-layer chromatography.
  328. Determination of Glycyrrhizin and glycyrrhetinic acid in traditional Chinese medicinal preparations by capillary electrophoresis.
  329. Determination of Glycyrrhizin and liquiritin in Shaogan capsules by HPLC [J]
  330. DETERMINATION OF Glycyrrhizin CONTENT AND SOME CHEMICAL COMPOUNDS OF GLYCYRRHIZA VARIETIES IN ARDABIL PROVINCE
  331. Determination of Glycyrrhizin glycyrrhizic acid and gentiopicrin in Liyanxiao particle and Liyanxiao traditional decoction by HPLC.
  332. Determination of Glycyrrhizin in Chinese prescriptions and biological samples by enzyme-linked immunosorbent assay
  333. Determination of Glycyrrhizin in Compound Glycyrrhizin Injection by RP-HPLC [J]
  334. Determination of Glycyrrhizin in Dog Plasma by Liquid Chromatography—Mass Spectrometry and its Application in Pharmacokinetic Studies
  335. Determination of Glycyrrhizin in Food by High Speed Liquid Chromatography
  336. Determination of Glycyrrhizin in glycyrrhiza and it’s preparations by ion-pair HPLC
  337. Determination of Glycyrrhizin in liqueurs by on-line coupled capillary isotachophoresis with capillary zone electrophoresis
  338. Determination of Glycyrrhizin in rabbit plasma by high-performance liquid chromatography with photodiode-array ultraviolet detection and its pharmacokinetics …
  339. Determination of Glycyrrhizin in Radix Glycyrrhizae and its preparation by HPLC
  340. Determination of Glycyrrhizin in Radix glycyrrhizae and its preparations by capillary zone electrophoresis
  341. Determination of Glycyrrhizin in Rat Plasma Administered with Shaoyao Gancao Decoction by RP-HPLC
  342. Determination of Glycyrrhizin in Shuangxiangpaishi Granules by HPLC [J]
  343. Determination of Glycyrrhizin in Zhenzhu Buccal Tablets by RP-HPLC
  344. Determination of liquiritin, Glycyrrhizin, hesperidin, cinnamic acid, cinnamaldehyde, honokiol and magnolol in the traditional Chinese medicinal preparation Wuu-Ji …
  345. Determination of paclitaxel in paclitaxel-liposomes surface-modified with Glycyrrhizin by HPLC
  346. Determination of puerarin, daidzein, paeoniflorin, cinnamic acid, Glycyrrhizin, ephedrine, and [6]-gingerol in Ge-gen-tang by micellar electrokinetic chromatography
  347. Determination of quercetin in lotus leaves extract and Glycyrrhizin in liquorice roots extract by spectrofluorimetric methods
  348. Determination of serum concentrations of Glycyrrhizin in humans by semi-micro high-performance liquid chromatography after administration of a therapeutic dose
  349. Determination of Sodium Saccharin and Glycyrrhizin in Food by High Performance Liquid Chromatography
  350. Determination of the Glycyrrhizin content in compound Glycyrrhizin dispersible tablets by HPLC
  351. Determination of the Related Substances of Compound Glycyrrhizin Tablet by RP-HPLC
  352. Determination of three kinds of component in compound Glycyrrhizin tablet by RP-HPLC [J]
  353. Determination of Three Kinds of Components in Compound Glycyrrhizin Tablet by RP-HPLC
  354. Determination of Two 18-Epimers of Glycyrrhizin by RP-HPLC [J]
  355. Determining Glycyrrhizin content in Glycyrrhizin injections by HPLC, vanillin-sulphuric acid colorimetry and UV spectrometry
  356. Development and validation of HPTLC method for determination of Glycyrrhizin in herbal extract and in herbal gel
  357. Development of a Biotransformation Process for Production of 18 B Glycyrrhetinic Acid from Glycyrrhizin
  358. Development of Glycyrrhizin-conjugated, chitosan-coated, lysine-embedded mesoporous silica nanoparticles for hepatocyte-targeted liver tissue regeneration
  359. Development of the Devices for Synthetic Biology of Glycyrrhizin at an Early Stage: Cloning and Sequencing Analysis of Farnesyl-Diphosphate Synthase Genes in …
  360. Differences in the metabolism of Glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid monoglucuronide by human intestinal flora
  361. Differential regulation of activator protein 1 activity by Glycyrrhizin
  362. Diprospan local injection of Compound Glycyrrhizin treatment of alopecia areata Efficacy
  363. Disposition of Glycyrrhizin in the perfused liver of rats
  364. Dissociated control by Glycyrrhizin of proliferation and IL-2 production of murine thymocytes
  365. Distribution and Metabolism of Magnesium IsoGlycyrrhizinate and Compound Glycyrrhizin in Rats’ Tissues [J]
  366. Distribution of enzymes involved in the metabolism of Glycyrrhizin in various organs of rat
  367. Dose-dependent neuroprotective effect of oriental phyto-derived Glycyrrhizin on experimental neuroterminal norepinephrine depletion in a rat brain model
  368. Dose-dependent pharmacokinetics of Glycyrrhizin in rats
  369. Down-regulation of a hepatic transporter Mrp2 is involved in alteration of pharmacokinetics of Glycyrrhizin and its metabolites in a rat model of chronic liver injury
  370. Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of Glycyrrhizin and its metabolites in a …
  371. Drug interactions between hepatoprotective agents ursodeoxycholic acid or Glycyrrhizin and ombitasvir/paritaprevir/ritonavir in healthy Japanese subjects
  372. Effect Analysis of the Compound Glycyrrhizin Glucoside United Adefovir Ester Treatment of Chronic Hepatitis B
  373. Effect and Mechanism of Glycyrrhizin in Preventing and Curing Diabetic Nephropathy
  374. Effect Observation of Compound Glycyrrhizin in the Treatment of Anaphylactoid Purpura of Children [J]
  375. Effect observation of compound Glycyrrhizin tablets, levocetirizine combined with triclosan cream in chronic eczema
  376. Effect Observation of Levocetirizine Hydrochoride Combined with Compound Glycyrrhizin in Treating Chronic Eczema
  377. Effect of 18β-Glycyrrhizin on pharmacokinetics of glimepiride in rats
  378. Effect of additives on accumulation of Glycyrrhizin in suspension culture cells of Glycyrrhiza uralensis
  379. Effect of ammoniated Glycyrrhizin on the mineral utilization of rats
  380. Effect of compoud Glycyrrhizin tablets in the treatment of chronic eczema [J]
  381. Effect of Compoud Glycyrrhizin Tablets in Ttreating Patients with Hand Eczema
  382. Effect of compound Glycyrrhizin and vitiligo pill on vitiligo
  383. Effect of compound Glycyrrhizin combined with fexofenadine hydrochloride in the treatment of chronic urticaria and its influence on plasma histamine
  384. Effect of compound Glycyrrhizin combined with NB-UVB on T lymphocyte subsets and related cytokines in patients with psoriasis vulgaris
  385. Effect of Compound Glycyrrhizin Combined with Puerarin on Serum Levels of IL-6 and TNF-α in NAFLD Patients [J]
  386. Effect of compound Glycyrrhizin combing with acyclovir and neurotropin on postherpetic neuralgia
  387. Effect of compound Glycyrrhizin in the management of tuberculosis in reducing incidence of drug-induced liver injury
  388. Effect of compound Glycyrrhizin injection combined with polyene phosphatidylcholine injection on chronic hepatitis B [J]
  389. Effect of compound Glycyrrhizin injection on liver function and cellular immunity of children with infectious mononucleosis complicated liver impairment
  390. Effect of compound Glycyrrhizin injection on the treatment of patients with chronic hepatitis B and influence to serum TNF-α and IL-6 [J]
  391. Effect of Compound Glycyrrhizin on Activities of SOD, MDA and MPO in TNBS-Induced Colitis Rats [J]
  392. Effect of compound Glycyrrhizin on airway inflammation in asthmatic rats
  393. Effect of compound Glycyrrhizin on alcoholic fatty liver disease
  394. Effect of Compound Glycyrrhizin on Hepatic Function of Reserve in Patients with Chronic Fulminate Hepatitis [J]
  395. Effect of compound Glycyrrhizin on ischemia/reperfusion injury in the skeletal muscle of rabbits*,⋆
  396. Effect of compound Glycyrrhizin on peripheral T-lymphocyte subset in AIDS patients
  397. Effect of Compound Glycyrrhizin on serum expression of IL-4, IL-10 and IL-17 in adjuvant arthritis rat
  398. Effect of drought stress on growth parameters, osmolyte contents, antioxidant enzymes and Glycyrrhizin synthesis in licorice (Glycyrrhiza glabra L.) grown in the field
  399. Effect of elicitors on accumulation of Glycyrrhizin in the suspension culture cells of Glycyrrhiza uralensis
  400. Effect of Glycyrrhiza glabra roots and Glycyrrhizin on the glucuronidation in rats
  401. Effect of Glycyrrhiza glabra Roots and Glycyrrhizin on the Glucuronidation in Rats
  402. Effect of Glycyrrhizin (GL) on β-defensin production in tissues surrounding the burn area of thermally injured mice (134.44)
  403. Effect of Glycyrrhizin Acid on Expression of Renal Interstitial Fibrosis and its Mechanism in Rats with Unilateral Ureteral Obstruction
  404. Effect of Glycyrrhizin and its diastereoisomers on the growth of human tumour cells: Preliminary findings
  405. Effect of Glycyrrhizin capsule and Yangxueshengfa on alopecia areata
  406. Effect of Glycyrrhizin combined with puerarin on serum leptin and insulin resistance in patients with non-alcoholic fatty liver disease
  407. Effect of Glycyrrhizin glabra in nutrient on sexual desire and semen parameters of bulls born in Iraq during winter
  408. Effect of Glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection
  409. Effect of Glycyrrhizin on aging changes of peptidergic neurons in central amygdaloid nucleus of rats
  410. Effect of Glycyrrhizin on CCl_4-induced liver cirrhosis and bone loss in mice
  411. Effect of Glycyrrhizin on CCl_4-induced liver cirrhosis and bone loss in mice [J]
  412. Effect of Glycyrrhizin on cortisol metabolism in humans.
  413. Effect of Glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes
  414. Effect of Glycyrrhizin on cytokine induction in murine monocyte macrophage in vitro
  415. Effect of Glycyrrhizin on Eotaxin Expression in Lung Tissue in Asthmatic Model Mice
  416. Effect of Glycyrrhizin on Eotaxin Expression in Lung Tissue in Asthmatic Model Mice [J]
  417. Effect of Glycyrrhizin on estrogen action
  418. Effect of Glycyrrhizin on Experimental Mastitis by Staphylococcus Aureus in Mice
  419. Effect of Glycyrrhizin on glutathione S-transferase activity and glutathione in rats intoxicated with carbon tetrachloride
  420. Effect of Glycyrrhizin on haptoglobin mRNA expression in mice epidermis of contact dermatitis
  421. Effect of Glycyrrhizin on hepatic lysosomal systems
  422. Effect of Glycyrrhizin on hepatitis B e antigen and Toll-like receptor 4 in HepG 2.2. 15 cell line
  423. Effect of Glycyrrhizin on Heptitis B Virus Infection in HepG2. 2.15 Cell Line
  424. Effect of Glycyrrhizin on heptitis B virus infection in HepG2. 2.15 cell line.
  425. Effect of Glycyrrhizin on liver fibrosis in unmatured Wistar rats
  426. Effect of Glycyrrhizin on lysis of hepatocyte membranes induced by anti‐liver cell membrane antibody
  427. Effect of Glycyrrhizin on Lysosomes Labilization by Phospholipase A2
  428. Effect of Glycyrrhizin on Nitric Oxide and Nitric Oxide Synthase in Mice Model of Pronchial Asthma [J]
  429. Effect of Glycyrrhizin on pain and HLA-DR antigen expression on CD8-positive cells in peripheral blood of herpes zoster patients in comparison with other antiviral …
  430. Effect of Glycyrrhizin on plasma endothelin and serum nitric oxide in myocardial ischemia reperfusion rabbits
  431. Effect of Glycyrrhizin on pseudomonal skin infections in human-mouse chimeras
  432. Effect of Glycyrrhizin on rainbow trout Oncorhynchus mykiss leukocyte responses
  433. Effect of Glycyrrhizin on serum levels of PDGF, IL-17, MCP-1 and SRF in patients with glioma
  434. Effect of Glycyrrhizin on stability of lysosomes in the rat arterial wall.
  435. Effect of Glycyrrhizin on subcellular structure and protein expression in acute damaged HepG2 cells
  436. Effect of Glycyrrhizin on the activity of CYP3A enzyme in humans
  437. Effect of Glycyrrhizin on the Differentiation of 3T3-L1 Cell
  438. EFFECT OF Glycyrrhizin ON THE INTERFERON-γPRODUCTION OF HUMAN NEONATAL CORD BLOODMONONUCLEAR CELLS
  439. Effect of Glycyrrhizin on the intratracheal infection of Klebsiella pneumoniae in NOD/scid IL-2Rγnull mice inoculated with alcoholic patient white blood cells (IRC4P …
  440. Effect of Glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate
  441. Effect of Glycyrrhizin on the phosphatidylcholine-water system ESR and calorimetric study
  442. Effect of Glycyrrhizin on the production of platelet-activating factor from rat peritoneal exudate cells
  443. Effect of Glycyrrhizin on the suppressive action of cortisone on the pituitary adrenal axis
  444. Effect of Glycyrrhizin on traumatic brain injury in rats and its mechanism
  445. Effect of Glycyrrhizin on viral replication and quasispecies in patients with type C chronic hepatitis
  446. Effect of Glycyrrhizin Polysaccharide on Hemoglobin and Macrophage of Mice
  447. Effect of Glycyrrhizin pretreatment on metabolism of antipyrine and acetaminophen in mice [J]
  448. Effect of Glycyrrhizin-18α on the expression of p21 protein in renal tubular epithelial cells after renal ischemical reperfusion injury [J]
  449. Effect of Glycyrrhizin‐containing toothpaste on dental plaque reduction and gingival health in humans: a pilot study
  450. Effect of Glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients
  451. Effect of Glycyrrhizin, cyclosporin A, and tumor necrosis factor α on infection of U‐937 and MRC‐5 cells by human cytomegalovirus
  452. Effect of harvest time and root diameter on Glycyrrhizin content in Glycyrrhiza glabra
  453. Effect of HMGB1 and RAGE on brain injury and the protective mechanism of Glycyrrhizin in intracranial‑sinus occlusion followed by mechanical thrombectomy …
  454. Effect of hot water extract of a Glycyrrhizin-deficient strain of Glycyrrhiza uralensis on contact hypersensitivity in mice
  455. Effect of licorice and Glycyrrhizin on murine liver CYP-dependent monooxygenases
  456. Effect of liquorice and Glycyrrhizin on rat liver carcinogen metabolizing enzymes
  457. Effect of long-term coadministration of compound Glycyrrhizin tablets on the pharmacokinetics of mycophenolic acid in rats
  458. Effect of microbial load on therapeutically active constituent Glycyrrhizin of Glycyrrhiza glabra L.
  459. Effect of oral administration of Glycyrrhizin on the pharmacokinetics of prednisolone
  460. Effect of oxymatrin and Glycyrrhizin on hepatocyte apoptosis induced by cessation of phenobarbital treatment in mice
  461. Effect of paeoniflorin, Glycyrrhizin and glycyrrhetic acid on ovarian androgen production
  462. Effect of pH on metabolism of Glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid monoglucuronide by collected human intestinal flora
  463. Effect of Retinoic Acid, Glycyrrhizin and 18β-Glycyrrhetinic Acid on Proliferation Inhibition and Anti-invasion in Human Lung Cancer Cells [J]
  464. Effect of Schisandrae Fructus on Glycyrrhizin content in Kampo extracts containing Glycyrrhizae Radix used clinically in Japan
  465. Effect of shakuyaku-kanzo-to, shakuyaku, kanzo, paeoniflorin, glycyrrhetinic acid and Glycyrrhizin on ovarian function in rats
  466. Effect of Shear Rate on the Aggregation Behavior of Self-Aggregated Glycyrrhizin Micelles by MesoDyn
  467. Effect of soapwort root extract and Glycyrrhizin on consumer acceptance, texture, and oil separation of pistachio halva
  468. Effect of Soapwort Root Extract and Glycyrrhizin on Consumer Acceptance, Texture, and Oil Separation of Pistachio Halva
  469. Effect of the Compatibility of Aconite and Glycyrrhiza on the Contents of Aconitine, Glycyrrhizin and Liquirtin [J]
  470. Effect of Tiopronin Combined with Compound Glycyrrhizin on Treatment of Alcoholic Liver Disease
  471. Effect of vitiligo treatment using compound Glycyrrhizin combined with fractional carbon dioxide laser and topical triamcinolone acetonide on serum interleukin-17 and …
  472. Effect of Yiqi Yangxue Huayu Tang Combined with Compound Glycyrrhizin Tablets for Chronic Liver Disease on Liver Fibrosis and Liver Functions
  473. Effectiveness of Glycyrrhizin for oral lichen planus in patients with chronic HCV infection
  474. Effectiveness of interferon, Glycyrrhizin combination therapy in patients with chronic hepatitis C
  475. Effects and cost of Glycyrrhizin in the treatment of upper respiratory tract infections in members of the Japanese maritime self-defense force: Preliminary report of a …
  476. Effects of 18α-Glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis
  477. Effects of 18α-Glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats
  478. Effects of Antibiotics on LPS Induced Liver Cell Injury and Hepatoprotective Activity of Compound Ammonium Glycyrrhizin
  479. Effects of arbuscular mycorrhizal fungi on the growth, nutrient uptake and Glycyrrhizin production of licorice (Glycyrrhiza uralensis Fisch)
  480. Effects of baicailin combined with Glycyrrhizin on experimental asthma in guinea pigs [J]
  481. Effects of combination of Glycyrrhizin acid, ligustrazine and puerarin on LPS-induced cytokines expression in macrophage
  482. Effects of compound Glycyrrhizin injection by different administration route on rats with experimental acute hepatic failure [J]
  483. Effects of Compound Glycyrrhizin injection on the proliferation of human liver cells in vitro
  484. Effects of Compound Glycyrrhizin on Chemotactic Factors’ Expression in Peripheral Blood Mononuclear Cells
  485. Effects of Compound Glycyrrhizin on Chronic Hepatitis B
  486. Effects of compound Glycyrrhizin on immune function of children with Henoch-Schonlein purpura
  487. Effects of compound Glycyrrhizin on liver function in patients with alcoholic liver disease: a meta-analysis
  488. Effects of compound Glycyrrhizin on liver injury due to antituberculosis drugs: clinical observation of 20 cases.
  489. Effects of compound Glycyrrhizin preparation on IL-17 and ANA in patients with chronic hepatitis B
  490. Effects of Dietary Glycyrrhizin on Growth and Nonspecific Immunity of White Shrimp, Litopenaeus vannamei
  491. Effects of dietary Glycyrrhizin on growth, immunity of sea cucumber and its resistance against Vibrio splendidus.
  492. Effects of dietary magnesium and Glycyrrhizin on experimental atheromatosis of rats (long-term experiment)
  493. Effects of dietary β-glucan and Glycyrrhizin on non-specific immunity and disease resistance of the sea cucumber (Apostichopus japonicus Selenka) challenged with …
  494. Effects of dietary β‐glucan and Glycyrrhizin on non‐specific immunity and disease resistance of white shrimp, Litopenaeus vannamei (Boone) challenged with Vibrio …
  495. Effects of discontinuous administration of β-glucan and Glycyrrhizin on the growth and immunity of white shrimp Litopenaeus vannamei
  496. Effects of glucose, fructose and 5‐hydroxymethyl‐2‐furaldehyde on the presystemic metabolism and absorption of Glycyrrhizin in rabbits
  497. Effects of Glycyrrhizin (SNMC: Stronger Neo-Minophagen C®) in hemophilia patients with HIV infection
  498. Effects of Glycyrrhizin (SNMC: Stronger Neo-Minophagen C®) in hemophilia patients with HIV-1 infection
  499. Effects of Glycyrrhizin acid and licorice flavonoids on LPS-induced cytokines expression in macrophage
  500. Effects of Glycyrrhizin and cortisone on cholesterol metabolism in the rat
  501. Effects of Glycyrrhizin and glycyrrhetic acid on the growth, Glycyrrhizin β-D-glucuronidase and 3β-hydroxysteroid dehydrogenase of human intestinal bacteria
  502. Effects of Glycyrrhizin and Glycyrrhetic Acid on the Growth, Glycyrrhizin/3-1)-Glueuronidase and 3fl-Hydroxysteroid Dehydrogenase of Human Intestinal Bacteria
  503. Effects of Glycyrrhizin and glycyrrhetinic acid on (Na++ K+)-ATPase of renal basolateral membranes in vitro.
  504. Effects of Glycyrrhizin and glycyrrhetinic acid on dexamethasone-induced changes in histamine synthesis of mouse mastocytoma P-815 cells and in histamine release …
  505. Effects of Glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells
  506. Effects of Glycyrrhizin and platycodin on phospholipase A~ 2 activity in vitro
  507. Effects of Glycyrrhizin in a mouse model of lung adenocarcinoma
  508. Effects of Glycyrrhizin in anticancer activity and toxicity induced by anticancer drugs
  509. Effects of Glycyrrhizin on a drug resistant isolate of Pseudomonas aeruginosa
  510. Effects of Glycyrrhizin on activities of peritoneal macrophages of mice.
  511. Effects of Glycyrrhizin on airway mucus hypersecretion induced by interleukin-13 in rats
  512. Effects of Glycyrrhizin on biliary transport and hepatic levels of glutathione in rats
  513. Effects of Glycyrrhizin on blood pressure and its mechanisms
  514. Effects of Glycyrrhizin on C6 Glioma Cells, with Special Reference to Cell Proliferation and Cell—Specific Proteins
  515. Effects of Glycyrrhizin on genes expression during the process of liver fibrosis
  516. Effects of Glycyrrhizin on glucocorticoid signaling pathway in hepatocytes
  517. Effects of Glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study
  518. Effects of Glycyrrhizin on immune‐mediated cytotoxicity
  519. Effects of Glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model
  520. Effects of Glycyrrhizin on mitochondrial ATPase and membrane fluidity in canine brain following cardiac arrest and resuscitation
  521. Effects of Glycyrrhizin on Phenotypic and Biological Function of Dendritic Cells (DCs)
  522. Effects of Glycyrrhizin on production of vascular aldosterone and corticosterone
  523. Effects of Glycyrrhizin on Proliferation, Activation and Synthesis of Extracellular Matrix in Rat Hepatic Stellate Cell
  524. Effects of Glycyrrhizin on Proteinuria in rats with adriamycin nephropathy [J]
  525. Effects of Glycyrrhizin on renal functions in association with the regulation of water channels
  526. Effects of Glycyrrhizin on Smad7 in CC1_4 Induced Rat Liver Fibrosis [J]
  527. Effects of Glycyrrhizin on TGFbeta1 stimulated hepatic stellate cell signaling transduction
  528. Effects of Glycyrrhizin on the differentiation of myeloid cells of the heart and lungs in lipopolysaccharide-induced septic mice
  529. Effects of Glycyrrhizin on the expression of hepatitis B virus and Toll like receptors 2, 4 in HepG2. 2.15 cells expressing low HBsAg
  530. Effects of Glycyrrhizin on the expressions of glucocorticoid receptor and NF-κB in lung of rat with acute lung injury
  531. Effects of Glycyrrhizin on the expressions of IL-2 and IL-4 in HaCaT cells
  532. Effects of Glycyrrhizin on the Metabolism of Lipids in Rats of Acute Ethanol Intoxication
  533. Effects of Glycyrrhizin on the pharmacokinetics of asiatic acid in rats and its potential mechanism
  534. Effects of Glycyrrhizin on the Pharmacokinetics of Matrine in Rats
  535. Effects of Glycyrrhizin on the pharmacokinetics of paeoniflorin in rats and its potential mechanism
  536. Effects of Glycyrrhizin on the pharmacokinetics of puerarin in rats
  537. Effects of Glycyrrhizin on the proliferation of ASMC induced by fetal calf or histamine in rats
  538. Effects of Glycyrrhizin on thymolytic and immunosuppressive action of cortisone
  539. Effects of Glycyrrhizin on Urine Protein in Children with Nephrotic Syndrome
  540. Effects of Glycyrrhizin on UVB-irradiated melanoma cells
  541. Effects of Glycyrrhizin pre-treatment on transient ischemic brain injury in mice
  542. Effects of Glycyrrhizin pre-treatment on transient middle cerebral artery occlusion induced brain injury in mice
  543. Effects of Glycyrrhizin-18? on expressions of CTGF and TGF-? 1 in renal interstitium in rats with obstructive nephropathy
  544. Effects of Glycyrrhizin-18# alpha# on expressions of CTGF and TGF-# beta# 1 in renal interstitium in rats with obstructive nephropathy
  545. Effects of Glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice
  546. Effects of Glycyrrhizin, glycyrrhiza polysaccharide and glabridin on the toxicity and immunologic function of murine peritoneal macrophages.
  547. EFFECTS OF Glycyrrhizin, SILYMARIN, CITRUS PEAL AND JUICE ON AFLATOXIN B_1-INDUCED HEPATOCARCINOGENESIS IN RATS [J]
  548. Effects of modifiers on the supercritical CO2 extraction of Glycyrrhizin from licorice and the morphology of licorice tissue after extraction
  549. Effects of nutrient solution concentration on inorganic and Glycyrrhizin contents of Glycyrrhiza glabra Linn
  550. Effects of preoperative Glycyrrhizin infusion for the prevention of venous thrombosis on the tissue expression of antithrombin in a rat model
  551. Effects of radix bupleuri and Glycyrrhizin on the hepatocyte apoptosis in mice
  552. Effects of radix bupleuri and Glycyrrhizin on the hepatocyte apoptosis in mice
  553. Effects of Sho-saiko-to extract and its components, Baicalin, baicalein, Glycyrrhizin and glycyrrhetic acid, on pharmacokinetic behavior of salicylamide in carbon …
  554. Effects of silymarin, Glycyrrhizin, and oxymatrine on the pharmacokinetics of ribavirin and its major metabolite in rats
  555. Effects of ultrasound on extraction of Glycyrrhizin from Glycyrrhiza glabra L. in comparison with modified Rosen’s method
  556. Efficacy and mechanism of compound Glycyrrhizin on serious hepatitis: report of 30 patients
  557. Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular Glycyrrhizin injections
  558. Efficacy and safety of Glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study
  559. Efficacy evaluation of compound Glycyrrhizin injection in the treatment of melasma
  560. Efficacy observation of combined therapy of Mizolastine and compound Glycyrrhizin for chronic urticaria [J]
  561. Efficacy Observation of Compound Glycyrrhizin Tablets Combined with Traditional Chinese Medicine in the Treatment of Chronic Eczema
  562. Efficacy Observation on 66 Cases of Simplex Anaphylactoid Purpura Treated by Compound Glycyrrhizin Combined with YIQING Capsules [J]
  563. Efficacy of a combination of NB-UVB, ganciclovir and Glycyrrhizin in the treatment of middle-aged and senile herpes zoster
  564. Efficacy of a combination therapy with compound tablet of Glycyrrhizin and loratadine in treatment of chronic urticaria of children
  565. Efficacy of a Glycyrrhizin suppository for the treatment of chronic hepatitis C: a pilot study
  566. Efficacy of compound Glycyrrhizin combined with narrow-band ultraviolet B in treatment of atopic dermatitis [J]
  567. Efficacy of compound Glycyrrhizin combined with reduced glutathione in patients with alcoholic liver disease
  568. Efficacy of compound Glycyrrhizin injection plus tablets for liver prophylaxis for inpatients with hepatitis induced by anti-tuberculosis drugs
  569. Efficacy of interferon combined Glycyrrhizin therapy in patients with chronic hepatitis C resistant to interferon therapy
  570. Efficacy of Intravenous Glycyrrhizin for the Treatment of Chronic Hepatitis C: A Comparison of the Original and Generic Drugs
  571. Efficacy of intravenous Glycyrrhizin in the early stage of acute onset autoimmune hepatitis
  572. Efficacy of protective mechanism of compound Glycyrrhizin on acute hepatic failurein rats [J]
  573. Efficaly of the combination of compound Glycyrrhizin and becotide to treat oral lichen planus
  574. Efficient method for determining the Glycyrrhizin content of fresh and dried roots, and root extracts, of Glycyrrhiza species
  575. Elicitation as yield enhancement strategy for Glycyrrhizin production by cell cultures of Abrus precatorius Linn.
  576. Elicitation Enhanced the Yield of Glycyrrhizin and Antioxidant Activities in Hairy Root Cultures of Glycyrrhiza glabra L.
  577. Elucidation on abnormal behavior of Glycyrrhizin salts in high performance liquid chromatography determination for quasi-drug products
  578. Engineering of Glycyrrhizin capped gold nanoparticles for liver targeting: in vitro evaluation and in vivo biodistribution study
  579. Enhanced Glycyrrhizin production in Glycyrrhiza inflata hairy roots cultures using elicitation
  580. Enhanced yeast surface display of β‐glucuronidase using dual anchor motifs for high‐temperature Glycyrrhizin hydrolysis
  581. Enhancement of interferon-γ production in Glycyrrhizin-treated human peripheral lymphocytes in response to concanavalin A and to surface antigen of hepatitis B virus
  582. Enhancement of nitric oxide production from activated macrophages by Glycyrrhizin
  583. Enhancing the thermostability of β-glucuronidase from T. pinophilus enables the biotransformation of Glycyrrhizin at elevated temperature
  584. Enzyme leakage due to change of membrane permeability of primary cultured rat hepatocytes treated with various hepatotoxins and its prevention by Glycyrrhizin
  585. Enzyme-linked immunosorbent assay for Glycyrrhizin using anti-Glycyrrhizin monoclonal antibody and an eastern blotting technique for glucuronides of glycyrrhetic …
  586. Eosinophilic peritonitis responding to treatment with Glycyrrhizin.
  587. Epac1 and Glycyrrhizin Both Inhibit HMGB1 Levels to Reduce Diabetes-Induced Neuronal and Vascular Damage in the Mouse Retina
  588. Erratum to: Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats
  589. Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound Glycyrrhizin
  590. EST analysis reveals putative genes involved in Glycyrrhizin biosynthesis
  591. Estimation of Impurities from Commercially Available Glycyrrhizin Standards by the HPLC/ESI-MS
  592. Evaluation of anti-diabetic activity of Glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats
  593. Evaluation of antidepressant-like activity of Glycyrrhizin in mice
  594. Evaluation of callus cultures of Glycyrrhiza glabra L. var. HM 1 for Glycyrrhizin.
  595. Evaluation of clinical efficacy of Glycyrrhizin and ranitidine in the treatment of chronic urticaria
  596. Evaluation of gene resources collection of liquorice (Glycyrrhiza L., Fabaceae)-content of Glycyrrhizin
  597. Evaluation of Glycyrrhizin variation in Gancao collected from 1986 to 2000 at drug markets in Japan and discrimination of Daitou-Gancao and Dongbei-Gancao
  598. Evaluation of long-term treatment with Glycyrrhizin and of combination therapy with Glycyrrhizin and AZT or DDI on HIV-1 carriers
  599. Evaluation of phytochemical, antioxidant and antimicrobial properties of Glycyrrhizin extracted from roots of Glycyrrhiza Glabra
  600. Evaluation of surfactant assisted pressurized liquid extraction for the determination of Glycyrrhizin and ephedrine in medicinal plants
  601. Evaluation of the hepatoprotective effect of combination between hinokiflavone and Glycyrrhizin against CCl4 induced toxicity in rats
  602. Evaluation of the immunity activity of Glycyrrhizin in AR mice
  603. Excretion profile of Glycyrrhizin metabolite in human urine
  604. Experiment Study of Glycyrrhizin anti-HSV-1 [J]
  605. Experimental investigation and modelling of inulin and Glycyrrhizin extraction
  606. Experimental study of effects of Glycyrrhizin on intercellular adhesion function in acute cerebral ischemia in rats
  607. Experimental study on anti-HSV-Ⅰ mechanism of Glycyrrhizin [J]
  608. Experimental study on inhibitory effect of Glycyrrhizin on HSV-1 in vitro
  609. Experimental study on inhibitory effect of Glycyrrhizin on HSV-1 in vitro [J]
  610. Explore pharmacological mechanism of Glycyrrhizin based on systems pharmacology
  611. Expression of junB is markedly stimulated by Glycyrrhizin in a human hepatoma cell line. Erratum in/or/31/2/1030
  612. Extraction of Glycyrrhizin from licorice (Glycyrrhiza Glabra L.) by bulk liquid membrane
  613. EXTRACTUM GLYCYRRHIZAE DEPURATUM AND AMMONIACAL Glycyrrhizin.
  614. Fas-mediated apoptosis is enhanced by Glycyrrhizin without alteration of caspase-3-like activity
  615. Feature selection and interpretation in infrared quantitative models of liquiritin and Glycyrrhizin in radix glycyrrhizae
  616. Formation of a monoclonal antibody against Glycyrrhizin and development of an ELISA
  617. Functional specialization of UDP‐glycosyltransferase 73P12 in licorice to produce a sweet triterpenoid saponin, Glycyrrhizin
  618. Fungitoxic and growth-promoting propoties of the complexs copper component and Glycyrrhizin acid
  619. Gastrointestinal absorption characteristics of Glycyrrhizin from glycyrrhiza extract
  620. Gene expression of Glycyrrhizin acid and accumulation of endogenous signaling molecule in Glycyrrhiza uralensis Fisch adventitious roots after Saccharomyces cerevisiae and …
  621. Geographic variation and ecological mechanism of growth characteristics and Glycyrrhizin content of annual Gancao (Radix Glycyrrhizae)
  622. Glycyrrhetic acid (a metabolic substance and aglycon of Glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells
  623. Glycyrrhiza glabra L. (Licorice): Cell Culture, Regeneration, and the Production of Glycyrrhizin
  624. Glycyrrhiza/Glycyrrhizin Pseudoaldosteronism in elderly patients: 5 case
  625. Glycyrrhizin (20β-carboxy-11-oxo-30-norolean-12-en-3β-yl-2-O-β-d-glucopyranuronosyl-α-d-glucopyranosiduronic acid) improves the resistance of thermally injured …
  626. Glycyrrhizin (GL) improves the resistance of humanized NSG chimeras intradermally infected with Pseudomonas aeruginosa (162.12)
  627. Glycyrrhizin (GL) modulates HMGB1/miR-222-associated M2bMφ polarization and improves host antibacterial resistance of γ-irradiated mice against gut bacteria …
  628. Glycyrrhizin (licorice)-induced hypokalemic myopathy
  629. Glycyrrhizin 18α-assisted treatment for 73 cases of acyclovir-induced acute renal failure
  630. Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats
  631. Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma
  632. Glycyrrhizin acid prevent hydrochloric acid-induced inhalational lung injury in mice through inhibition of MAPK pathway
  633. Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice
  634. Glycyrrhizin administration ameliorates Streptococcus aureus-induced acute lung injury
  635. Glycyrrhizin affects monocyte migration and apoptosis by blocking HMGB1 signaling
  636. Glycyrrhizin Affects the Pharmacokinetics of Omeprazole in Rats through Inducing the Activity of CYP3A4, CYP2C19, and P-gp
  637. Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25
  638. Glycyrrhizin alleviates experimental allergic asthma in mice
  639. Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice
  640. Glycyrrhizin alleviates nonalcoholic steatohepatitis via modulating bile acids and meta-inflammation
  641. Glycyrrhizin ameliorate ischemia reperfusion lung injury through downregulate TLR2 signaling cascade in alveolar macrophages
  642. Glycyrrhizin ameliorates atopic dermatitis-like symptoms through inhibition of HMGB1
  643. Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells
  644. Glycyrrhizin ameliorates fibrosis, vasculopathy, and immune abnormalities in animal models of systemic sclerosis
  645. Glycyrrhizin ameliorates fibrosis, vasculopathy, and inflammation in animal models of systemic sclerosis
  646. Glycyrrhizin ameliorates high fat diet-induced obesity in rats by activating NrF2 pathway
  647. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-a-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells
  648. Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway
  649. Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model
  650. Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model
  651. Glycyrrhizin ameliorates oxidative stress and inflammation in hippocampus and olfactory bulb in lithium/pilocarpine-induced status epilepticus in rats
  652. Glycyrrhizin ameliorates renal function defects in the early‐phase of ischemia‐induced acute renal failure
  653. Glycyrrhizin and 18 beta-glycyrrhetinic acid: a comparative study of the pharmacological effects induced in the rat after prolonged oral treatment.
  654. Glycyrrhizin and glycyrrhetic acid: scaffolds to promising new pharmacologically active compounds
  655. Glycyrrhizin and glycyrrhetinic acid determination from formalin-fixed tissue
  656. Glycyrrhizin and glycyrrhetinic acid directly modulate rat cardiac performance
  657. Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption
  658. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor Toll‐like receptor 4/MD‐2 complex signaling in a different manner
  659. Glycyrrhizin and its metabolite 18β-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of …
  660. Glycyrrhizin and its metabolite inhibit Smad3-mediated type I collagen gene transcription and suppress experimental murine liver fibrosis
  661. Glycyrrhizin and licorice significantly affect the pharmacokinetics of methotrexate in rats
  662. Glycyrrhizin and long-term histopathologic changes in a murine model of asthma
  663. Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
  664. Glycyrrhizin and serum testosterone concentrations in male patients with type 2 diabetes
  665. Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors
  666. Glycyrrhizin as a potential treatment for chronic hepatitis C
  667. Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes.
  668. Glycyrrhizin as antiviral agent against Hepatitis C Virus
  669. Glycyrrhizin attenuates endotoxin-induced acute liver injury after partial hepatectomy in rats
  670. Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis
  671. Glycyrrhizin attenuates histamine-mediated MUC5AC upregulation, inflammatory cytokine production, and aquaporin 5 downregulation through suppressing the NF …
  672. Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway
  673. Glycyrrhizin attenuates isoflurane-induced cognitive deficits in neonatal rats via its anti-inflammatory activity
  674. Glycyrrhizin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus
  675. Glycyrrhizin attenuates MPTP neurotoxicity in mouse and MPP+-induced cell death in PC12 cells
  676. Glycyrrhizin attenuates mucus production by inhibition of MUC5AC mRNA expression in vivo and in vitro
  677. Glycyrrhizin attenuates proinflammatory cytokines through a peroxisome proliferator-activated receptor-γ-dependent mechanism and experimental vasospasm in a rat …
  678. Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1
  679. Glycyrrhizin attenuates Salmonella enterica serovar Typhimurium infection: new insights into its protective mechanism
  680. Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice
  681. Glycyrrhizin Attenuates the Process of Epithelial-to-Mesenchymal Transition by Modulating HMGB1 Initiated Novel Signaling Pathway in Prostate Cancer Cells
  682. Glycyrrhizin attenuates tissue injury and reduces neutrophil accumulation in experimental acute pancreatitis
  683. Glycyrrhizin attenuates toll like receptor-2,-4 and experimental vasospasm in a rat model
  684. Glycyrrhizin binding site on human serum albumin
  685. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities
  686. Glycyrrhizin combined with acitretin improve clinical symptom of psoriasis via reducing Th17 cell differentiation and related serum cytokine concentrations
  687. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte‐targeted delivery of lamivudine
  688. Glycyrrhizin conjugated dendrimer and multi-walled carbon nanotubes for liver specific delivery of doxorubicin
  689. Glycyrrhizin could inhibit HMGB1-MMP-9 signaling and prevent hemorrhagic transformation in ischemic stroke with delayed t-PA treatment
  690. Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits
  691. Glycyrrhizin derivative inhibits eotaxin 1 production via STAT6 in human lung fibroblasts
  692. Glycyrrhizin down-regulates CCL2 and CXCL2 expression in cerulein-stimulated pancreatic acinar cells
  693. Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis
  694. Glycyrrhizin enhances interleukin‐12 production in peritoneal macrophages
  695. Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis
  696. Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression
  697. Glycyrrhizin exhibits potential chemopreventive activity on 12-O-tetradecanoyl phorbol-13-acetate-induced cutaneous oxidative stress and tumor promotion in swiss …
  698. Glycyrrhizin for Chronic Hepatitis: Protocol of Systematic Review of Randomized Controlled Trials
  699. Glycyrrhizin GEL AS A VEHICLE FOR IDOXURIDINE–I. CLINICAL INVESTIGATIONS
  700. Glycyrrhizin gel as vehicle for idoxuridine topical preparation: skin permeation behaviour.
  701. Glycyrrhizin has a high likelihood to be a victim of drug–drug interactions mediated by hepatic organic anion‐transporting polypeptide 1B1/1B3
  702. Glycyrrhizin Improves Fatty Liver Symptoms, Increases Adiponectin and Reduces UCP2 Expression in Wistar Rats
  703. Glycyrrhizin improves p75NTR‑associated sciatic nerve regeneration in a BALB/c mouse model
  704. Glycyrrhizin improves the antimicrobial peptide production by human epidermal keratinocytes (NHEK) transwell-cultured with peripheral blood linage-CD34+ cells, a …
  705. Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses
  706. Glycyrrhizin in patients who failed previous interferon alpha‐based therapies: biochemical and histological effects after 52 weeks
  707. Glycyrrhizin inactivates toll‐like receptor (TLR) signaling pathway to reduce lipopolysaccharide‐induced acute lung injury by inhibiting TLR2
  708. Glycyrrhizin increases survival of mice with herpes simplex encephalitis.
  709. Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells
  710. Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP
  711. Glycyrrhizin Induces Apoptosis In Prostate Cancer Cell lines DU-145 and LNCaP
  712. Glycyrrhizin induces autophagic cell death in MHCC97-H cell line in vitro
  713. Glycyrrhizin induces melanogenesis by elevating a cAMP level in b16 melanoma cells
  714. Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney
  715. Glycyrrhizin induces reactive oxygen species-dependent apoptosis and cell cycle arrest at G0/G1 in HPV18+ human cervical cancer HeLa cell line
  716. Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages
  717. Glycyrrhizin inhibits human neutrophil elastase-induced mucin 5AC overproduction in human bronchial epithelial cells
  718. Glycyrrhizin inhibits human parainfluenza virus type 2 replication by the inhibition of genome RNA, mRNA and protein syntheses
  719. Glycyrrhizin Inhibits IL-8 Production and NF-κB Activity in Lung Epithelial Cells, But Not Through Glucocorticoid Receptors
  720. Glycyrrhizin inhibits influenza A virus uptake into the cell
  721. Glycyrrhizin Inhibits Interleukin-8 Production and Nuclear Factor–κB Activity in Lung Epithelial Cells, but Not Through Glucocorticoid Receptors
  722. Glycyrrhizin inhibits lipopolysaccharide-induced inflammatory response by reducing TLR4 recruitment into lipid rafts in RAW264. 7 cells
  723. Glycyrrhizin inhibits LPS-induced inflammatory mediator production in endometrial epithelial cells
  724. Glycyrrhizin inhibits neutrophil-associated generation of alternatively activated macrophages
  725. Glycyrrhizin inhibits porcine epidemic diarrhea virus infection and attenuates the proinflammatory responses by inhibition of high mobility group box-1 protein
  726. Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats
  727. Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine
  728. Glycyrrhizin inhibits the expression of monocyte chemoattractant protein 1 in bleomycin-induced pulmonary fibrosis of rats
  729. Glycyrrhizin inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model
  730. Glycyrrhizin Inhibits the Lytic Pathway of Complement—Possible Mechanism of Its Anti‐Inflammatory Effect on Liver Cells in Viral Hepatitis—
  731. Glycyrrhizin inhibits the manifestations of anti-inflammatory responses that appear in association with systemic inflammatory response syndrome (SIRS)-like reactions
  732. Glycyrrhizin inhibits TNF-induced, but not Fas-mediated, apoptosis in the human hepatoblastoma line HepG2
  733. Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1–RAGE interaction
  734. Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon‐resistant active chronic hepatitis C
  735. Glycyrrhizin OR DERIVATIVES THEREOF FOR TREATING OR PREVENTING SEVERE ACUTE RESPIRATORY SYNDROME (SARS)
  736. Glycyrrhizin prevents 7-ketocholesterol toxicity against differentiated PC12 cells by suppressing mitochondrial membrane permeability change
  737. Glycyrrhizin Prevents Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke with Delayed Thrombolysis Through Targeting …
  738. Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats
  739. Glycyrrhizin prevents liver injury by inhibition of HMGB1 production by kupffer cells after ischemia-reperfusion in rats
  740. Glycyrrhizin prevents of lipopolysaccharide/D‐galactosamine‐induced liver injury through down‐regulation of matrix metalloproteinase‐9 in mice
  741. Glycyrrhizin production by in vitro cultured Glycyrrhiza glabra elicited by methyl Jasmonate and salicylic acid
  742. Glycyrrhizin production in hairy root cultures of Glycyrrhiza uralensis induced triterpenoid biosynthetic gene
  743. Glycyrrhizin protection against 3-morpholinosydnonime-induced mitochondrial dysfunction and cell death in lung epithelial cells
  744. Glycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α–Mediated Apoptosis
  745. Glycyrrhizin protects against focal cerebral ischemia via inhibition of T cell activity and HMGB1-mediated mechanisms
  746. Glycyrrhizin protects against porcine endotoxemia through modulation of systemic inflammatory response
  747. Glycyrrhizin protects against sodium iodate‐induced RPE and retinal injury though activation of AKT and Nrf2/HO‐1 pathway
  748. Glycyrrhizin protects brain against ischemia–reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway
  749. Glycyrrhizin protects human melanocytes from H2O2‑induced oxidative damage via the Nrf2‑dependent induction of HO‑1
  750. Glycyrrhizin protects IGFBP-3 knockout mice from retinal damage
  751. Glycyrrhizin protects mice against experimental autoimmune encephalomyelitis by inhibiting high-mobility group box 1 (HMGB1) expression and neuronal …
  752. Glycyrrhizin protects mice against renal ischemia‑reperfusion injury through inhibition of apoptosis and inflammation by downregulating p38 mitogen …
  753. Glycyrrhizin protects mice from concanavalin A-induced hepatitis without affecting cytokine expression.
  754. Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway
  755. Glycyrrhizin protects rats from sepsis by blocking HMGB1 signaling
  756. Glycyrrhizin protects spinal cord and reduces inflammation in spinal cord ischemia–reperfusion injury
  757. Glycyrrhizin protects the diabetic retina against permeability, neuronal, and vascular damage through anti-inflammatory mechanisms
  758. Glycyrrhizin Protects γ-Irradiated Mice from Gut Bacteria–Associated Infectious Complications by Improving miR-222–Associated Gas5 RNA Reduction in …
  759. Glycyrrhizin reduces HMGB1 and bacterial load in Pseudomonas aeruginosa keratitis
  760. Glycyrrhizin reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and endotoxemic mice by p38/Nrf2-dependent induction of HO-1
  761. Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice
  762. Glycyrrhizin regulates CD4+ T cell response during liver fibrogenesis via JNK, ERK and PI3K/AKT pathway
  763. Glycyrrhizin relieves pulmonary fibrosis by Bleomycin in rats
  764. Glycyrrhizin renders cells resistant to apoptosis induced by human and feline immunodeficiency virus
  765. Glycyrrhizin represses total parenteral nutrition-associated acute liver injury in rats by suppressing endoplasmic reticulum stress
  766. Glycyrrhizin restores impaired antimicrobial peptide production by human skin tissues cultured with immature myeloid suppressor cells (162.13)
  767. Glycyrrhizin restores the impaired IL-12 production in thermally injured mice
  768. Glycyrrhizin restores the impaired production of β-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas …
  769. Glycyrrhizin stimulates growth of Eubacterium sp. strain GLH, a human intestinal anaerobe.
  770. Glycyrrhizin suppresses HMGB1 inductions in the hippocampus and subsequent accumulation in serum of a kainic acid-induced seizure mouse model
  771. Glycyrrhizin suppresses inflammation and cell apoptosis by inhibition of HMGB1 via p38/p-JUK signaling pathway in attenuating intervertebral disc …
  772. Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase
  773. Glycyrrhizin suppresses RANKL-Induced osteoclastogenesis and oxidative stress through inhibiting NF-κB and MAPK and activating AMPK/Nrf2
  774. Glycyrrhizin suppresses the expressions of HMGB1 and ameliorates inflammative effect after acute subarachnoid hemorrhage in rat model
  775. Glycyrrhizin suppresses the expressions of HMGB1 and relieves the severity of traumatic pancreatitis in rats
  776. Glycyrrhizin suppresses the growth of human NSCLC cell line HCC827 by downregulating HMGB1 level
  777. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery
  778. Glycyrrhizin therapy for viral infections
  779. Glycyrrhizin treatment facilitates extinction of conditioned fear responses after a single prolonged stress exposure in rats
  780. Glycyrrhizin treatment for Chronic Hepatitis C
  781. Glycyrrhizin treatment inhibits proliferation and invasive potential of lung cancer cells
  782. Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide …
  783. Glycyrrhizin variability in subterranean organs of Sardinian Glycyrrhiza glabra subspecies glabra var. glabra
  784. Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B
  785. Glycyrrhizin β-D-glucuronidase of Eubacterium sp. from human intestinal flora
  786. Glycyrrhizin 유도체인 2-Acetoxy 11-Keto 30-Acetoxymethyl Keto Oleanenic Acid 와 부신피질 Hormone 분비와의 관계
  787. Glycyrrhizin 이 각종약물의 마우스 치사율에 미치는 영향
  788. Glycyrrhizin-18α protects against renal ischemia-reperfusion injury by upregulating p53 expression [J]
  789. Glycyrrhizin-assisted transport of praziquantel anthelmintic drug through the lipid membrane: an experiment and MD simulation
  790. Glycyrrhizin-containing suppository compositions for rectal infusion
  791. Glycyrrhizin-INDUCED INHIBITION OF THE PITUITARY-ADRENAL STRESS RESPONSE
  792. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C
  793. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma
  794. Glycyrrhizin, a direct HMGB1 antagonist, ameliorates inflammatory infiltration in a model of autoimmune thyroiditis via inhibition of TLR2-HMGB1 signaling
  795. Glycyrrhizin, a high-mobility group box 1 inhibitor, improves lipid metabolism and suppresses vascular inflammation in apolipoprotein E knockout mice
  796. Glycyrrhizin, a Potential Drug for Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1
  797. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus.
  798. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
  799. Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium‐pilocarpine‐induced status epilepticus
  800. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats
  801. Glycyrrhizin, silymarin, and ursodeoxycholic acid regulate a common hepatoprotective pathway in HepG2 cells
  802. Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling
  803. Glycyrrhizin: A Review
  804. Glycyrrhizin/diuretics
  805. Glycyrrhizin/oral contraceptives
  806. Growth and Glycyrrhizin contents in Glycyrrhiza uralensis roots cultivated for four years in eastern Nei-Meng-gu of China
  807. Growth characteristics, Glycyrrhizin and free sugar content of Licorice species
  808. Hasty effect on the metabolism of Glycyrrhizin by Eubacterium sp. GLH with Ruminococcus sp. PO1-3 and Clostridium innocuum ES24-06 of human intestinal bacteria
  809. HEMORRHEOLOGICAL CHANGES IN PATIENTS WITH PSORIASIS TREATED BY COMPOUND Glycyrrhizin COMBINED WITH DANSHEN INJECTION
  810. Hepatic gene delivery system electrostatically assembled with Glycyrrhizin
  811. Hepatic protection by Glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice
  812. Hepato-protective Activity of Glycyrrhizin, Liquiritin and Isoliquiritigenin on HL-7702 Cells Injury Induced by Acetaminophen [J]
  813. Hepatoprotective and anti-hepatocarcinogenic effects of Glycyrrhizin and matrine
  814. Hepatoprotective Effect of Compound Glycyrrhizin on Patients Undergoing Transcatheter Hepatic Arterial Chemoembolization [J]
  815. Hepatoprotective effects of a proprietary Glycyrrhizin product during alcohol consumption: A randomized, double‐blind, placebo‐controlled, crossover study
  816. Hepatoprotective Effects of a Proprietary Glycyrrhizin Product during Alcohol Consumption: A Randomized, Doubleâ Blind, Placeboâ Controlled, Crossover Study
  817. Hepatoprotective effects of Glycyrrhizin and omega-3 fatty acids on Nuclear Factor-kappa B pathway in thioacetamide-induced fibrosis in rats
  818. Hepatoprotective effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in combination: a possible synergy
  819. Hepatoprotective liposomal Glycyrrhizin in alcoholic liver injury
  820. High Liquid Chromatography Used in Determination of Concentration of Glycyrrhizin in Plasma of Rats with Spleen Deficiency and Pharmacokinetics of Glycyrrhizin [J]
  821. High-performance liquid chromatographic determination of Glycyrrhizin and glycyrrhetinic acid in biological materials
  822. High-performance liquid chromatographic determination of Glycyrrhizin in licorice products
  823. Histopathologic and MRI findings in hypokalemic myopathy induced by Glycyrrhizin
  824. HMGB1 inhibitor Glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats
  825. HPLC analysis of Glycyrrhizin and licochalcone a in Glycyrrhiza inflata from Xinjiang (China)
  826. HPLC determination of 18α-and 18 β-Glycyrrhizin for quality control of Glycyrrhizin products
  827. HPLC determination of 18α-and 18 β-Glycyrrhizin for quality control of Glycyrrhizin products [J]
  828. HPLC determination of 18β-glycyrrhetinic acid urine excretion profile after ingestion of Glycyrrhizin
  829. HPLC determination of ammonium Glycyrrhizinate in compound Glycyrrhizin tablets [J]
  830. HPLC determination of ephedrine hydrochloride and glycyrrhizic acid in compound Glycyrrhizin ephedrine tablets [J]
  831. HPLC determination of Glycyrrhizin and glycyrrhetic acid in biological fluids, after licorice extract administration to humans and rats.
  832. HPTLC Densitometric Quantification of Glycyrrhizin, Glycyrrhetinic Acid, Apigenin, Kaempferol and Quercetin from Glycyrrhiza glabra
  833. HPTLC densitometric quantification of Glycyrrhizin, glycyrrhetinic acid, apigenin, kaempferol and quercetin from Glycyrrhiza glabra.
  834. Humectant containing alpha-glycosyl Glycyrrhizin as active ingredient and use thereof
  835. Hydrolysis of Glycyrrhizin to 18β-glycyrrhetyl monoglucuronide by lysosomal β-d-glucuronidase of animal livers
  836. Hypertensive crisis with 2 target organ impairment induced by Glycyrrhizin: A case report
  837. Hypertensive retinopathy and papilledema. Apropos of a case of Glycyrrhizin poisoning
  838. Hypokalemia and sodium retention in patients with diabetes and chronic hepatitis receiving insulin and Glycyrrhizin
  839. Identification and simultaneous determination of Glycyrrhizin, formononetin, glycyrrhetinic acid, liquiritin, isoliquiritigenin, and licochalcone A in licorice by LC-MS/MS
  840. Identification of Glycyrrhizin as a thrombin inhibitor
  841. Identification of Glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study
  842. Identification of Glycyrrhizin-binding protein kinase as casein kinase II and characterization of its associated phosphate acceptors in mouse liver
  843. Immobilization of purified β-glucuronidase on ZnO nanoparticles for efficient biotransformation of Glycyrrhizin in ionic liquid/buffer biphasic system
  844. Immunoregulatory effects of compound ammonium Glycyrrhizin soluble powder on liver injury induced by enrofloxacin and LPS in chickens
  845. Improved phosphorus nutrition by arbuscular mycorrhizal symbiosis as a key factor facilitating Glycyrrhizin and liquiritin accumulation in Glycyrrhiza uralensis
  846. Improved production of human beta-defensins (HBDs) in grafted site skin tissues of human IMC/mouse chimeras treated with Glycyrrhizin (GL)(118.14)
  847. Improvement in the bioavailability of poorly absorbed Glycyrrhizin via various non-vascular administration routes in rats
  848. Improvement of oral bioavailability of Glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles
  849. Improvement of selectivity and sensitivity by column switching in the determination of Glycyrrhizin and glycyrrhetic acid in human plasma by high-performance liquid …
  850. Improvement on Preparation Technology of Mongolian Medicine Glycyrrhizin
  851. Improving the thrombin inhibitory activity of Glycyrrhizin, a triterpenic saponin, through a molecular simplification of the carbohydrate moiety
  852. In silico Comparative Molecular Docking Study and Analysis of Glycyrrhizin from Abrus precatorius (L.) against Antidiabetic Activity
  853. In Situ Biotransformation of Glycyrrhizin Under Different State of Fermentation (Liquid and Solid–Liquid) Conditions by E. coli
  854. In vitro and in vivo evaluation of the enhancing activity of Glycyrrhizin on the intestinal absorption of drugs
  855. In vitro anti-Helicobacter pylori activity of Extractum liquiritiae, Glycyrrhizin and its metabolites
  856. In vitro antiviral activity of indigenous Glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus.
  857. In vitro Effects of Glycyrrhizin on the Serum Enzymes in Chronic Hepatitis Patients
  858. In vitro induction of anti-type 2 T cells by Glycyrrhizin
  859. In vitro Inhibition of Sindbis Virus Replication by Glycyrrhizin
  860. In vitro plasma protein binding of 18H-Glycyrrhizin in human by GC
  861. In vitro studies on the effect of Glycyrrhizin from Indian Glycyrrhiza glabra Linn on some RNA and DNA viruses
  862. In vivo Glycyrrhizin accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized rats
  863. Incorporation of Glycyrrhizin, sorbitol and fructose in formulating dietetic sour cherry jam and its effect on NIDDM patients
  864. Increase in the level of proinflammatory cytokine HMGB1 in nasal fluids of patients with rhinitis and its sequestration by Glycyrrhizin induces eosinophil cell …
  865. Induction of Glycyrrhizin and total phenolic compound production in licorice by using arbuscular mycorrhizal fungi
  866. Induction of T lymphocyte apoptosis by treatment with Glycyrrhizin
  867. Influence of Agrobacterium rhizogenes strains and elicitation on hairy root induction and Glycyrrhizin production from Abrus precatorius
  868. Influence of Compound Glycyrrhizin Injection on Hormone Withdrawal Syndrome in SARS Patients
  869. Influence of compound Glycyrrhizin on liver functions, liver fibrosis indexes and inflammatory factors of patients with chronic hepatitis B
  870. Influence of Compound Glycyrrhizin on Serum TNF-α and IL-6 in Patients with Chronic Hepatitis B [J]
  871. Influence of fungal elicitation on Glycyrrhizin production in transformed cell cultures of Abrus precatorius Linn
  872. Influence of Glycyrrhizin on intestinal absorption of paeoniflorin by the everted rat gut sac model [J]
  873. Influence of Glycyrrhizin on paeoniflorin pharmacokinetic fate in unrestrained conscious rats by intravenous administration
  874. Influence of Glycyrrhizin on permeability and elasticity of cell membrane: perspectives for drugs delivery
  875. Influence of Glycyrrhizin on the evolution and respiration of Ehrlich ascites tumour cells.
  876. Influence of honey on the gastrointestinal metabolism and disposition of Glycyrrhizin and glycyrrhetic acid in rabbits
  877. Influence of Various Bile Acids on the Metabolism of Glycyrrhizin and Glycyrrhetic Acid by Ruminococcus sp. P01-3 of Human Intestinal Bacteria
  878. Influence of various bile acids on the metabolism of Glycyrrhizin and glycyrrhetic acid by Ruminococcus sp. PO1-3 of human intestinal bacteria
  879. Influence on Glycyrrhizin in Different Ratio Compatibility of Radix Aconiti Lateralis Preparata and Radix Glycytthizae [J]
  880. Influences and therapeutic effects of compound Glycyrrhizin combined with ligustrazine on hepatic fibrosis indexes of chronic hepatitis B
  881. Inhibition effect of Glycyrrhizin in lipopolysaccharide-induced high-mobility group box 1 releasing and expression from RAW264. 7 cells
  882. Inhibition effect of Glycyrrhizin on transplanted mandibular gland fibrosarcoma of mice
  883. Inhibition of airway MUC5AC mucin production and gene expression induced by epidermal growth factor or phorbol ester by Glycyrrhizin and carbenoxolone
  884. Inhibition of burn‐associated suppressor cell generation by Glycyrrhizin through the induction of contrasuppressor T cells
  885. Inhibition of hepatocellular carcinoma by Glycyrrhizin in diethylnitrosamine-treated mice
  886. Inhibition of High Mobility Group Box 1–Toll-Like Receptor-4 Signaling by Glycyrrhizin Contributes to the Attenuation of Cold Ischemic Injury of Liver in a Rat Model
  887. Inhibition of IL-6 and IL-8 production in LPS-stimulated human gingival fibroblasts by Glycyrrhizin via activating LXRα
  888. Inhibition of intercellular adhesion in herpex simplex virus infection by Glycyrrhizin
  889. Inhibition of mouse skin tumor‐initiating activity of DMBA by chronic oral feeding of Glycyrrhizin in drinking water
  890. Inhibition of mutagenicity by glycyrrhiza extract and Glycyrrhizin
  891. Inhibition of Oxidative Tissue Damage and Mitochondrial Dysfunction by Glycyrrhizin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine Mouse Model of …
  892. Inhibition of phospholipase A2 and platelet aggregation by Glycyrrhizin, an antiinflammation drug.
  893. Inhibition of the activity of glucosyltransferase from Streptococcus mutans by Glycyrrhizin
  894. Inhibitory actions of phospholipase A2 and saponins including ginsenoside Rb1 and Glycyrrhizin on the formation of nicotinic acetylcholine receptor clusters on …
  895. Inhibitory effect of Glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma.
  896. Inhibitory effect of Glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury
  897. Inhibitory effect of Glycyrrhizin on NF-kappa B binding activity in CCl4 plus ethanol induced liver cirrhosis in rats
  898. Inhibitory effect of Glycyrrhizin on NF‐κB binding activity in CC14‐ plus ethanol‐induced liver cirrhosis in rats
  899. Inhibitory effect of Glycyrrhizin on polypeptide phosporylation by polypeptide-dependent protein kinase (Kinase P) invitro
  900. Inhibitory effect of Glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]
  901. Inhibitory effect of Glycyrrhizin on the neutrophil‐dependent increase of R5 HIV replication in cultures of macrophages
  902. Inhibitory effect of Glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro
  903. Inhibitory effect of Glycyrrhizin on the production of CCL2 by various sources of immunosuppressive neutrophils (PMN-II)
  904. Inhibitory Effects of Glycyrrhiza glabra and Its Major Constituent Glycyrrhizin on Inflammation-Associated Corneal Neovascularization
  905. Inhibitory Effects of Glycyrrhizin on Scratching Behavior in Response to Substance P, PAR—2 Agonist, and LTB4 in Mice
  906. Injectable hydrogels based on Glycyrrhizin, alginate, and calcium for three‐dimensional cell culture in liver tissue engineering
  907. Interaction Analysis of Glycyrrhizin on Licorice Extract-Induced Apoptosis of Human Leukemia Cells by Knockout Extract
  908. Interaction of Glycyrrhizin and glycyrrhetinic acid with DNA
  909. Interaction of Glycyrrhizin with human haemoglobin
  910. Interaction of licorice on Glycyrrhizin pharmacokinetics.
  911. Interactions of Glycyrrhizin with organic anion transporting polypeptides of rat and human liver
  912. Interference Test of Filter Film Adsorption for Dissolution of Compound Glycyrrhizin Tablets
  913. Interferon induction by Glycyrrhizin and glycyrrhetinic acid in mice
  914. Interferon, ribavirin, 6-azauridine and Glycyrrhizin: antiviral compounds active against pathogenic flaviviruses
  915. Interventional Effect of Glycyrrhizin on Hydroxyproline, Hyaluronic Acid, and Laminin in Pulmonary Fibrosis Model Rats
  916. Intestinal bacterial hydrolysis is indispensable to absorption of 18β‐glycyrrhetic acid after oral administration of Glycyrrhizin in rats
  917. Intravenous Glycyrrhizin as a rescue therapy in a patient with latent hepatitis B virus reactivation and acute severe decompensation induced by chemotherapy with …
  918. Intravenous Glycyrrhizin for the treatment of chronic hepatitis C: a double‐blind, randomized, placebo‐controlled phase I/II trial
  919. Intravenous Glycyrrhizin improved serum transaminases rapidly in a chronic hepatitis B patient with acute exacerbation
  920. Investigation of interfacial behavior of Glycyrrhizin with a lipid raft model via a Langmuir monolayer study
  921. Investigation of the influence of Glycyrrhizin on the pharmacokinetics of celastrol in rats using LC-MS and its potential mechanism
  922. Investigations into the structure-function relationship of plant-based surfactant Glycyrrhizin: Interfacial behavior & emulsion formation
  923. Investigations into the Structure-Function Relationship of the Naturally-Derived Surfactant Glycyrrhizin: Emulsion Stability
  924. Iontophoretic Transdermal Delivery of Glycyrrhizin: Effects of pH, Drug Concentration, Co-ions, Current Intensity, and Chemical Enhancers
  925. Is Glycyrrhizin sensitivity increased in anorexia nervosa and should licorice be avoided? Case report and review of the literature
  926. Isolation and characterization of three fungi with the potential of transforming Glycyrrhizin
  927. Isolation and determination of Glycyrrhizin A and liquiritin from licorice
  928. Isolation and Purification of Glycyrrhizin from Licorice with Resin Column
  929. Isolation of a novel Glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism
  930. Isolation of bacterial strains, which hydrolyze Glycyrrhizin and produce glycyrrhezic acid, from soil
  931. Isoliquiritigenin and Glycyrrhizin inhibit the inflammasome activation in a different manner.(P1246)
  932. Kinetic analysis of glycyrrhetic acid, an active metabolite of Glycyrrhizin, in rats: role of enterohepatic circulation
  933. Kinetics of the gel—sol transition of the aqueous solutions of β-Glycyrrhizin studied by the temperature jump—spin probe method
  934. Lack of effect of continuous Glycyrrhizin administration on the pharmacokinetics of the P-glycoprotein substrate talinolol in healthy volunteers
  935. Lamivudine and Glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma
  936. Laxative action of sennoside A, which causes decreased colonic aquaporin‐3 expression, is controlled by the anti‐inflammatory effect of Glycyrrhizin
  937. Licorice compounds Glycyrrhizin and 18β-glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes
  938. Licorice β-amyrin 11-oxidase, a cytochrome P450 with a key role in the biosynthesis of the triterpene sweetener Glycyrrhizin
  939. Lipidomics investigation of reversal effect of Glycyrrhizin (GL) towards lithocholic acid (LCA)-induced alteration of phospholipid profiles
  940. Literature analysis of reports for adverse drug reactions of compound Glycyrrhizin injection
  941. Localization of Enzymes Involved in Metabolism of Glycyrrhizin in
  942. Localization of enzymes involved in metabolism of Glycyrrhizin in contents of rat gastrointestinal tract
  943. Long-term clinical outcome and effect of Glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon
  944. Long-term clinical outcome and effect of Glycyrrhizin in 1093 chronic hepatitis C patients with non-response to interferon
  945. Long-term treatment of chronic hepatitis C with Glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma
  946. Loss and Gain on Glycyrrhizin Content of Glycyrrhiza (Glycyrrhizae Radix) by Gamma-Ray Irradiation
  947. Mechanism of anti-inflammatory action of Glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation
  948. Mechanism of anti-inflammatory action of liquorice extract and Glycyrrhizin
  949. Mechanism of antihepatotoxic activity of Glycyrrhizin, I: Effect on free radical generation and lipid peroxidation
  950. Mechanism of gastrointestinal absorption of Glycyrrhizin in rats
  951. Mechanism of Glycyrrhizin in the treatment of chicken embryo allantoic cavity artery vasospasm
  952. Mechanism of Glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress
  953. Mechanism of inhibitory effect of Glycyrrhizin on replication of human immunodeficiency virus (HIV)
  954. Mechanisms of contrasuppressor T cell generation in mice stimulated with Glycyrrhizin
  955. Mechanisms underlying the activation of cytotoxic function mediated by hepatic lymphocytes following the administration of Glycyrrhizin
  956. Mesoscopic simulation studies on the aggregation behaviour of Glycyrrhizin micelles for drug solubilization
  957. Meta-analysis of the efficacy and safety of compound Glycyrrhizin in the treatment of dermatitis and eczema
  958. Metabolic activities of ginsenoside Rb1, baicalin, Glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora
  959. Metabolic Engineering of Glycyrrhizin Pathway by Over-Expression of Beta-amyrin 11-Oxidase in Transgenic Roots of Glycyrrhiza glabra
  960. Metabolism of Glycyrrhizin and baicalin by human intestinal bacteria
  961. Metabolism of Glycyrrhizin and glycyrrhetinic acid in the in situ vascularly perfused rat intestine-liver model
  962. Metabolism of Glycyrrhizin by human intestinal flora
  963. Methyl jasmonate elicitation enhances Glycyrrhizin production in Glycyrrhiza inflata hairy roots cultures
  964. Microbial Production of Glycyrrhetic Acid 3-O-Mono-β-D-Glucuronide from Glycyrrhizin by Cryptococcus magnus MG-27
  965. Micropropagation of Glycyrrhiza glabra Linn and induction of Glycyrrhizin through in vitro manipulations
  966. Mitigation of Hepato-Cellular Injury Caused by HAART with Glycyrrhizin
  967. Mitigation of hepato-cellular injury caused by HAART with Glycyrrhizin compound in patients co-infected with HIV and HCV
  968. Modification of Glycyrrhizin Glucuronide by Enzyme to Increasing Its Sweetness (Ⅱ) Purification and Characterization of β Glucuronidases
  969. Modulation by Glycyrrhizin of the cell-surface expression of H-2 class I antigens on murine tumour cell lines and normal cell populations.
  970. Modulation of PPARγ and TNFα by emu oil and Glycyrrhizin in ulcerative colitis
  971. Monoclonal Antibody-Based Enzyme-Linked Immunosorbent Assay for Glycyrrhizin and Its Aglicon, Glycyrrketic Acid
  972. Myotonic and repetitive discharges in hypokalemic myopathy associated with Glycyrrhizin-induced hypochloremia
  973. Nanoemulsions as vehicles for transdermal delivery of Glycyrrhizin
  974. Natural Functional Additive-Glycyrrhizin and Antioxidant [J]
  975. Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and Glycyrrhizin
  976. Neuroprotection of Glycyrrhizin against ischemic vascular dementia in vivo and glutamate-induced damage in vitro
  977. New and simple methylene blue colorimetric assay for Glycyrrhizin in pharmaceuticals
  978. Nitric oxide production in mouse peritoneal macrophages enhanced with Glycyrrhizin
  979. Novel formulations of a liver protection drug Glycyrrhizin
  980. Observation of Clinical Efficency of Compound Glycyrrhizin Combined with Desloratadine and Auto-blood Therapy in the Treatment of Chronic Urticaria [J]
  981. Observation of Clinical Efficency of Desloratadine Combined with Compound Glycyrrhizin in the Treatment of 66 Patients with Chronic Urticaria [J]
  982. Observation of clinical efficiency of compound Glycyrrhizin combined with desloratadine and auto-blood therapy in the treatment of chronic urticaria.
  983. Observation of clinical efficiency of levocetirizine combined with compound Glycyrrhizin in the treatment of chronic urticaria
  984. Observation of Compound Glycyrrhizin Combined with Intermittent Isotretinoin on Severe Acne [J]
  985. Observation of compound Glycyrrhizin injection to prevention PHC patient liver function damaged by gamma knife
  986. Observation of Curative Effect of the Binghuangfule Ointment Combined with Compound Glycyrrhizin in the Treatment of Psoriasis Vulgaris.[J]
  987. Observation of curative effects of compound Glycyrrhizin combined with ligustrazine on patients with alcoholic liver disease
  988. Observation of Curative Effects on Treating Chronic Urticaria with Compound Glycyrrhizin Concomitant with Cetirizine [J]
  989. Observation of effect of using compound Glycyrrhizin in treatment of tuberculous patients who had liver damage as result of using anti-tuberculous medication
  990. Observation of efficacy of compound Glycyrrhizin tablets combined with Loratadine tablets in treatment of chronic eczema.
  991. Observation of Efficiency of Compound Glycyrrhizin on Treating Patients with Alopecia Areata [J]
  992. Observation of Glycyrrhizin in the treatment of patients with drug-induced liver injuries.
  993. Observation of the Effects of Compound Flumetasone Ointment and Compound Glycyrrhizin Tablet in Treating Palmopantar Pustulosis
  994. Observation of the Effects of Compound Glycyrrhizin Tablet and Acitretin in Treating Psoriasis Vulgaris [J]
  995. Observation of the Effects of Compound Glycyrrhizin Tablet and Levocetirizine Hydrochloride Tablet in Treating Chronic Urticaria [J]
  996. Observation of the prevention of compound Glycyrrhizin associated with Deoxidized Glutathione in treating Liver injury induced by anti-tuberculosis drugs [J]
  997. Observation of the therapeutic effect of compound Glycyrrhizin injection on chronic hepatitis B [J]
  998. Observation of the Therapeutic Effect of Compound Glycyrrhizin on Hepatitis E of Cholestasis Type [J]
  999. Observation of the Therapeutic Effect of Compound Glycyrrhizin on Portal Hypertension Patients during the Perioperative Period
  1000. Observation of the Therapeutic Effects of Compound Glycyrrhizin Combined with Radix Salviae Miltior-rhizae on Hepatic Fibrosis [J]
  1001. Observation of the Therapeutic Effects of Compound Glycyrrhizin on Chronic Hepatitis C That of No Curative Effect with Interferon [J]
  1002. Observation of therapeutic effect of mizolastine combined with compound Glycyrrhizin in chronic idiopathic urticaria.
  1003. Observation of Winona gentle moisturizing cream combined compound Glycyrrhizin tablets in treatment of facial dermatitis of the glucocorticoid hormone-dependent
  1004. Observation on Curative Effect of Compound Glycyrrhizin Injection in the Treatment of Neonatal Hepatitis
  1005. Observation on Curative Effects of Compound Glycyrrhizin and Lamivudine Used Concomitantly in the Treatment of Chronic Type B Hepatitis
  1006. Observation on Efficacy of Compound Glycyrrhizin in Treating Chronic Hepatitis B Complicated with Active Cirrhosis
  1007. Observation on the control efficacy of compound Glycyrrhizin on preventing the hepatic lesion of antituberculosis drugs [J]
  1008. Observation on the Curative Effect of Compound Glycyrrhizin on Chronic Severe Hepatitis
  1009. Observation on the effect of compound Glycyrrhizin injection in the treatment of 68 newborn infants with neonatal hyperbilirubinemia [J]
  1010. Observation on the efficacy of compound Glycyrrhizin tablets combined with liquid nitrogen cryotherapy in treatment of viltiligo.
  1011. Observation on therapeutic effects of compound Glycyrrhizin in the treatment of chronic viral hepatitis B
  1012. Observation on Therapeutic Efficacy of Compound Glycyrrhizin for Neonatal Hyperbilirubinemia [J]
  1013. Observation on Treating Herpes Zoster with Compound Glycyrrhizin and Narrow-band Ultraviolet B [J]
  1014. Observing anti-inflammatory and anti-nociceptive activities of Glycyrrhizin through regulating COX-2 and pro-inflammatory cytokines expressions in mice
  1015. ON Glycyrrhizin.
  1016. One-step immunochromatographic separation and ELISA quantification of Glycyrrhizin from traditional Chinese medicines
  1017. Optimization of Anti-solvent Recrystallization of Glycyrrhizin Acid Powder Using Response Surface Methodology [J]
  1018. Optimization of Fermentation Medium for Glycyrrhizin Biotransformation to Monoglucuronyl-glycyrrhetinic Acid by Plackett-Burman and Box-Behnken Design
  1019. Optimization of Glycyrrhizin Acid Phospholipids/Bile Salts Mixed Micelles Prescription by Central Composite Design/Response Surface Methodology
  1020. Optimization of microwave-assisted extraction for the determination of Glycyrrhizin in menthazin herbal drug by experimental design methodology
  1021. Oxidative inactivation of liver mitochondria in high fructose diet‐induced metabolic syndrome in rats: effect of Glycyrrhizin treatment
  1022. Oxytocin influences the production of Glycyrrhizin from cell cultures of Abrus precatorius Linn.
  1023. P-117 analysis of expressed sequence tags from glycyrrhiza uralensis shed a light on genes related to Glycyrrhizin biosynthesis
  1024. Paradoxical effects of Glycyrrhizin on the induction of granulocytes and extrathymic T cells between normal mice and mice with preexisting granulocytosis
  1025. Pathologic characteristics of immunologic injury in primary cultured rat hepatocytes and protective effect of Glycyrrhizin in vitro
  1026. Pb2+ binding by polyaspartyl polymers and their application to Pb2+ removal from Glycyrrhizin
  1027. PHARMACEUTICAL COMPOSITION BASED ON Glycyrrhizin AND EG56 POLYMER FOR THE PREPARATION OF ANTI-INFLAMMATORY PRODUCTS
  1028. Pharmacoeconomic evaluation of domestic and imported Glycyrrhizin in treating 116 cases of chronic hepatitis B
  1029. Pharmacokinetic profile of Glycyrrhizin in healthy volunteers by a new high‐performance liquid chromatographic method
  1030. Pharmacokinetic profiles of Glycyrrhizin in patients with chronic hepatitis
  1031. Pharmacokinetics of glycyrrhetic acid, a major metabolite of Glycyrrhizin, in rats
  1032. Pharmacokinetics of Glycyrrhizin
  1033. Pharmacokinetics of Glycyrrhizin after intravenous administration to rats
  1034. Pharmacokinetics of Glycyrrhizin in normal and albumin‐deficient rats
  1035. Pharmacokinetics of Glycyrrhizin in rats with D-galactosamine-induced hepatic disease
  1036. Pharmacokinetics of intravenous Glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection
  1037. Pharmacological Properties of Traditional Medivines. XXV. Effects of Ephedrine, Amygdalin, Glycyrrhizin, Gypsum and Their Combinations on Body Temperature and …
  1038. Phenotypic and functional maturation of murine dendritic cells (DCs) induced by purified Glycyrrhizin (GL)
  1039. Physiological correlation between Glycyrrhizin, Glycyrrhizin‐binding lipoxygenase and casein kinase II
  1040. Pivotal Advance: Glycyrrhizin restores the impaired production of ß-defensins in tissues surrounding the burn area and improves the resistance of burn mice to …
  1041. Pivotal Advance: Glycyrrhizin restores the impaired production of β‐defensins in tissues surrounding the burn area and improves the resistance of burn mice to …
  1042. Plasma levels of D-dimer and von Willebrand factor and the therapeutic effect of compound Glycyrrhizin in children with cytomegalovirus hepatitis
  1043. Possible mechanism of steroid action of the plant herb extracts Glycyrrhizin, glycyrrhetinic acid, and paeoniflorin: inhibition by plant herb extracts of steroid protein …
  1044. Potential drug interactions associated with Glycyrrhizin and glycyrrhetinic acid
  1045. Powderd injecta of compounded Glycyrrhizin and preparing method
  1046. Practical optimization method for dual-flow countercurrent extraction: purification of Glycyrrhizin
  1047. Prediction of Glycyrrhizin disposition in rat and man by a physiologically based pharmacokinetic model
  1048. Prediction of Glycyrrhizin disposition in rat and man with liver failure by a physiologically based pharmacokinetic model
  1049. Pregnane X receptor mediated-transcription regulation of CYP3A by Glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid …
  1050. Preliminary evidence for inhibitory effect of Glycyrrhizin on HIV replication in patients with AIDS
  1051. Preliminary study in Glycyrrhizin content and its influencing factors of wild and cultivated in different region of China
  1052. Preliminary Study on Enzymatic Synthesis of Glycyrrhizin-mediated Liposome
  1053. Preliminary study on inhibitory effect of Glycyrrhizin on hepatic stellate cell proliferation [J]
  1054. Preparation and Characterization of Cr (Ⅲ)-Glycyrrhizin
  1055. Preparation and Characterization of Glycyrrhizin-Graphene Hybrid Materials
  1056. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with Glycyrrhizin for hepatocyte targeting
  1057. Preparation and properties of sustained-release pellets of Glycyrrhizin effective components
  1058. Preparation and rectal absorption of highly concentrated Glycyrrhizin solution
  1059. Preparation of bovine serum albumin nanoparticles surface-modified with Glycyrrhizin
  1060. Preparation of N-caproyl Chitosan Nanoparticles Surface-modified with Glycyrrhizin and Its Stability in Vitro
  1061. Preparation of PLGA microspheres encapsulating highly concentrated Glycyrrhizin and the bile elimination of Glycyrrhizin after subcutaneous administration in rats
  1062. Preparation of valaciclovir loaded bovine serum albumin nanoparticles surface-modified with Glycyrrhizin and its characteristics of targeting to liver
  1063. Preparative purification of Glycyrrhizin extracted from the root of liquorice using high-speed counter-current chromatography
  1064. Pressurized hot water extraction of berberine, baicalein and Glycyrrhizin in medicinal plants
  1065. Prevention and Treatment Effect of Compound Glycyrrhizin in 56 HBsAg Positive Patients with Tuberculosis
  1066. Prevention of alcohol-induced DNA damage by a proprietary Glycyrrhizin/D-mannitol product: A randomized, placebo-controlled, cross-over human study
  1067. Prevention of cancer chemotherapeutic agent-induced toxicity in postoperative breast cancer patients with Glycyrrhizin (SNMC)
  1068. Prevention of hepatotoxic responses to chemicals by Glycyrrhizin in rats
  1069. Prevention of venous thrombosis by preoperative Glycyrrhizin infusion in a rat model
  1070. Preventive effect of α-tocopherol and Glycyrrhizin against platelet-neutrophil complex formation induced by hemodialysis membranes
  1071. Preventive effects of Glycyrrhizin on estrogen-related endometrial carcinogenesis in mice
  1072. Principal Component Analysis and Cluster Analysis of Trace Elements in Glycyrrhizin on Chinese traditional medicine
  1073. Production of experimental hypertension and cardiovascular-renal lesions with licorice and ammoniated Glycyrrhizin
  1074. Production of Glycyrrhizin in callus cultures of licorice
  1075. Production of Glycyrrhizin in Cell Suspension of Glycyrrhiza Inflata Batalin Cultured in Bioreactor
  1076. Profound difference of metabolic pharmacokinetics between pure Glycyrrhizin and Glycyrrhizin in licorice decoction
  1077. Progress in the detection of Glycyrrhizin and glycyrrhetic acid in biological specimens
  1078. Proliferative Inhibition and Apoptotic Induction Effect of Glycyrrhizin on Human Breast Carcinoma Cells
  1079. Prolonged pseudoaldosteronism induced by Glycyrrhizin
  1080. Properties and structures of β-glucuronidases with different transformation types of Glycyrrhizin
  1081. Properties of Glycyrrhizin in Kampo extracts including licorice root and changes in the blood concentration of glycyrrhetic acid after oral administration of Kampo …
  1082. Protection by Glycyrrhizin against Warm Ischemia-Reperfusion–Induced Cellular Injury and Derangement of the Microcirculatory Blood Flow in the Rat Liver
  1083. Protection of liver cells from experimentally induced liver cell injury by Glycyrrhizin
  1084. Protective Effect of Compound Glycyrrhizin Injection on the Human Liver Cells Injured by Alcohol
  1085. Protective effect of compound Glycyrrhizin on hepatic injury induced by Con A
  1086. Protective effect of Glycyrrhizin and matrine on acute vanishing bile duct syndrome induced by alpha‐naphthylisothiocyanate in rats
  1087. Protective effect of Glycyrrhizin in mice with systemic Candida albicans infection and its mechanism
  1088. Protective effect of Glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells
  1089. PROTECTIVE EFFECT OF Glycyrrhizin ON DNA REPALR DURING ITS INHIBITION ON DEN-INDUCED HEPATOCARCINOGENESIS
  1090. Protective effect of Glycyrrhizin on myocardial ischemia/reperfusion injury‑induced oxidative stress, inducible nitric oxide synthase and inflammatory reactions …
  1091. Protective effect of Glycyrrhizin on nephrotic syndrome induced by adriamycin in rats
  1092. Protective effect of Glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats
  1093. Protective effect of Glycyrrhizin, glycyrrhetic acid and matrine on acute cholestasis induced by α-naphthyl isothiocyanate in rats
  1094. Protective Effects and Mechanisms of Glycyrrhizin and Oleanolic Acid Against Cadmium induced Hepatic Injury in Rats
  1095. Protective effects of compound ammonium Glycyrrhizin, L‑arginine, silymarin and glucurolactone against liver damage induced by ochratoxin A in primary …
  1096. Protective effects of Glycyrrhizin against β2-adrenergic receptor agonist-induced receptor internalization and cell apoptosis
  1097. Protective effects of Glycyrrhizin against β2-adrenergic receptor agonist-induced receptor internalization and cell apoptosis.
  1098. Protective effects of Glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model
  1099. Protective effects of Glycyrrhizin on adriamycin nephropathy in rats
  1100. Protective effects of Glycyrrhizin on experimental transforming growth factorβ1 [J]
  1101. Protective effects of Glycyrrhizin on gentamicin‐induced acute renal failure in rats
  1102. Protective Effects of Glycyrrhizin on LPS and Amoxicillin/Potassium Clavulanate-Induced Liver Injury in Chicken.
  1103. Protective effects of Glycyrrhizin on sub-chronic diazinon-induced biochemical, hematological alterations and oxidative stress indices in male Wistar rats
  1104. Protective mechanism of Glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice
  1105. Protective role of Glycyrrhizin on experimental obstructive nephropat hy in rats
  1106. Protective role of Glycyrrhizin on experimental obstructive nephropathy in rats
  1107. Pseudo‐aldosteronism’induced by intravenous Glycyrrhizin treatment of chronic hepatitis C patients
  1108. Pseudoaldosteronism caused by combined administration of cilostazol and Glycyrrhizin
  1109. Pseudoaldosteronism due to the concurrent use of two herbal medicines containing Glycyrrhizin: interaction of Glycyrrhizin with angiotensin-converting enzyme …
  1110. Pseudohyperaldosteronism caused by compound Glycyrrhizin injection [J]
  1111. Psoriasis vulgaris efficacy of narrow band UVB therapy combined with compound; Glycyrrhizin
  1112. Purification and characterization of 100-kDa Glycyrrhizin (GL)-Binding Protein (gp100) as an effective phosphate acceptor for CK-II and the effect of GL on the …
  1113. Purification and characterization of a highly selective Glycyrrhizin-hydrolyzing β-glucuronidase from Penicillium purpurogenum Li-3
  1114. Purification and characterization of Glycyrrhizin-β-d-glucuronidase and baicalin-β-d-glucuronidase from a commercial enzyme preparation
  1115. Purification and Enrichment of Glycyrrhizin by Foam Fractionation [J]
  1116. Purification of Glycyrrhizin from Glycyrrhiza uralensis Fisch with ethanol/phosphate aqueous two phase system
  1117. Purification of high-purity Glycyrrhizin from licorice using hydrophilic interaction solid phase extraction coupled with preparative reversed-phase liquid chromatography
  1118. Qualitative and Quantitative Study of Quercetin and Glycyrrhizin in In Vitro Culture of Liquorice (Glycyrrhiza glabra L.) and Elicitation with AgNO3
  1119. Quality assessment of randomized controlled trials of compound Glycyrrhizin for urticaria [J]
  1120. QUANTIFICATION OF Glycyrrhizin BIOMARKER IN GLYCYRRHIZA GLABRA RHIZOME AND BABY HERBAL FORMULATIONS BY VALIDATED RP-HPTLC …
  1121. Quantification of Glycyrrhizin biomarker in Glycyrrhiza glabra rhizome and baby herbal formulations by validated RP-HPTLC methods
  1122. Quantification of Glycyrrhizin in Glycyrrhiza glabra extract by validated HPTLC densitometry
  1123. QUANTITA TIVE EVALUATION OF THE EFFECTS OF Glycyrrhizin AND GYPENOSIDES ON PRENEOPLASTIC LESION OF RAT LIVER
  1124. Quantitative Estimation of Glycyrrhizin in Marketed Formulation by HPTLC
  1125. Quantitative evaluation of ocular anti-inflammatory drugs based on measurements of corneal temperature in rabbits: dexamethasone and Glycyrrhizin
  1126. Quantitative evaluation of the effects of Glycyrrhizin and gypenosides on preneoplastic lesion of rat liver
  1127. Radical scavenging ability of Glycyrrhizin
  1128. Rapid detection of Glycyrrhizin by immunochromatographic assay
  1129. Rapid estimation of Glycyrrhizin and glycyrrhetinic acid in plasma by high-speed liquid chromatography
  1130. Rapid Estimation of Glycyrrhizin in Pharmaceutical Preparations by High-Speed Liquid Chromatography
  1131. Recently Observation of 25 cases of Lichen Planus Treated with Compound Glycyrrhizin
  1132. Recovery of the impaired production of alpha-defensins (HNPs) in cultures of burn patient peripheral blood neutrophils treated with Glycyrrhizin (GL)(118.12)
  1133. Regenerative effects of Glycyrrhizin and/or platelet rich plasma on type-II collagen induced arthritis: Targeting autophay machinery markers, inflammation and …
  1134. Regulating effect of compound Glycyrrhizin on LPS-induced inflammatory factor release from murine RAW 264.7 cells
  1135. Regulatory Effect of Compound Glycyrrhizin on Th1/Th2 Cytokine in Alopecia Areata [J]
  1136. Regulatory effect of HMGB1 on the process of epithelial-mesenchymal transitionand reversal potential role of Glycyrrhizin on E-cadherin in prostate cancer cells
  1137. Relationship between DDR2 and alcoholic liver fibrosis and response of compound Glycyrrhizin tablets on them: an experimental study.
  1138. Renin-dependency of Glycyrrhizin-induced pseudoaldosteronism
  1139. Renoprotective effects of Glycyrrhizin on experimental glomerulosclerosis in rats.
  1140. Repetitive administration of Shaoyao‐Gancao‐tang to rats restores the bioavailability of Glycyrrhizin reduced by antibiotic treatment
  1141. Report of a case showing a recovery from liver cirrhosis to chronic hepatitis, type C, after Glycyrrhizin injection for 2 years and a sustained response by the following …
  1142. Research on the protective effect of Glycyrrhizin against renal ischemia-reperfusion injury in mice and its mechanisms
  1143. Research on the Variation of Glycyrrhizin Content in Different Glycyrrhiza uralensis Fisch Samples from A Single Farm [J]
  1144. Respective of the receptors for glycyrrhetinic and for Glycyrrhizin on isolated hepatocyte membranes
  1145. Responding to Treatment Glycyrrhizin
  1146. Reversed-phase high-performance thin-layer chromatographic method for the simultaneous determination of Glycyrrhizin and glabridin biomarkers in Glycyrrhiza …
  1147. Review of antiviral effects of Glycyrrhiza glabra L. and its active component, Glycyrrhizin
  1148. Ri-mediated Transformation of Glycyrrhiza uralensis with a Squalene Synthase Gene (GuSQS1) for Production of Glycyrrhizin
  1149. Role of compound Glycyrrhizin in clinical treatment [J]
  1150. Role of elevated fibrinogen in burn-induced mitochondrial dysfunction: protective effects of Glycyrrhizin
  1151. Role of glucocorticoid in the development of Glycyrrhizin-induced hypertension
  1152. Role of Glycyrrhizin in the reduction of inflammation in diabetic kidney disease
  1153. Role of Glycyrrhizin on bone marrow hematopoiesis in immune-induced aplastic anemia mice [J]
  1154. RP-HPLC determination of ammonium Glycyrrhizinate and related substances in compound Glycyrrhizin for injection
  1155. RP-HPLC determination of ammonium Glycyrrhizinate and related substances in compound Glycyrrhizin for injection
  1156. Safety and effectiveness of compound Glycyrrhizin in the treatment of non-alcoholic fatty liver disease
  1157. Screening and establishment of the high-Glycyrrhizin strain of licorice, Glycyrrhiza uralensis
  1158. Screening strains for directed biosynthesis of β-D-mono-glucuronide-Glycyrrhizin and kinetics of enzyme production
  1159. Seasonal variation of Glycyrrhizin and isoliquiritigenin glycosides in the root of Glycyrrhiza glabra L.
  1160. Selective activation of extrathymic T cells in the liver by Glycyrrhizin
  1161. Selective depletion of Glycyrrhizin from Si-Ni-San, a traditional Chinese prescription, blocks its effect on contact sensitivity in mice and recovers adhesion and …
  1162. Selective high-performance liquid chromatographic method for the determination of Glycyrrhizin and glycyrrhetic acid-3-O-glucuronide in biological fluids: application …
  1163. Selectivity of action of Glycyrrhizin derivatives on the growth of MCF-7 and HEP-2 cells.
  1164. Sensitive detection of Glycyrrhizin and evaluation of the affinity constants by a surface plasmon resonance-based immunosensor
  1165. Separation and analysis of Glycyrrhizin, 18β-glycyrrhetic acid and 18α-glycyrrhetic acid in liquorice roots by means of capillary zone electrophoresis
  1166. Separation of phospholipase A2 in Habu snake venom by Glycyrrhizin (GL)-affinity column chromatography and identification of a GL-sensitive enzyme
  1167. Si-Ni-San, a traditional Chinese prescription, and its active ingredient Glycyrrhizin ameliorate experimental colitis through regulating cytokine balance
  1168. Sildenafil citrate-Glycyrrhizin/Eudragit binary spray dried microparticles: A sexual behavior studies on male rats
  1169. Simultaneous analysis of Glycyrrhizin, paeoniflorin, quercetin, ferulic acid, liquiritin, formononetin, benzoic acid and isoliquiritigenin in the Chinese proprietary …
  1170. Simultaneous analysis of liquiritin and Glycyrrhizin in Sagunja-tang by HPLC-PDA
  1171. Simultaneous Determination and Pharmacokinetic Characterization of Glycyrrhizin, Isoliquiritigenin, Liquiritigenin, and Liquiritin in Rat Plasma Following Oral …
  1172. Simultaneous determination of albiflorin, cinnamaldehyde, cinnamic acid, daidzin, Glycyrrhizin, liquiritin, paeoniflorin and puerarin in Galgeun-tang by HPLC …
  1173. Simultaneous determination of baicalin and Glycyrrhizin in Eul-Ja-Tang by HPLC/DAD
  1174. Simultaneous determination of baicalin and Glycyrrhizin in Sosiho-tang by HPLC and anti-inflammatory activity
  1175. Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, berberine, coptisine, palmatine, jateorrhizine and Glycyrrhizin in Kampo medicines by ion …
  1176. Simultaneous Determination of Chlorogenic Acid, Phillyrin, Arctiin, Liquiritin and Glycyrrhizin in Yinqiao Powder by HPLC [J]
  1177. Simultaneous Determination of Curcumin and Glycyrrhizin Contents by High-performance Liquid Chromatography in Two Different Oriental Herbal …
  1178. SIMULTANEOUS DETERMINATION OF FERULIC ACID, HESPERIDIN, 6-GINGEROL AND Glycyrrhizin IN INSAMPAEDOK-SAN BY HPLC COUPLED WITH …
  1179. Simultaneous determination of ferulic acid, hesperidin, 6-gingerol and Glycyrrhizin in Insampaedok-san by HPLC coupled with diode array detection
  1180. Simultaneous determination of glycine and cyeteine hydrochloride in compound Glycyrrhizin injection by HPLC [J]
  1181. Simultaneous determination of Glycyrrhizin and 15 flavonoids in licorice and blood by high performance liquid chromatography with ultraviolet detector
  1182. Simultaneous determination of Glycyrrhizin metabolites formed by the incubation of Glycyrrhizin with rat feces by semi-micro high-performance liquid chromatography
  1183. Simultaneous determination of Glycyrrhizin, a marker component in radix Glycyrrhizae, and its major metabolite glycyrrhetic acid in human plasma by LC–MS/MS
  1184. Simultaneous Determination of Glycyrrhizin, Glycyrrhetic Acid and Glycyrrhetic Acid Mono-Glucuronide in Shakuyaku-kanzo-to Incubated with Rat Feces by Semi …
  1185. Simultaneous determination of Glycyrrhizin, liquiritin and isoliquritigenin in licorice by HPLC.
  1186. Simultaneous determination of hesperidin and Glycyrrhizin in Pyungwi-san by HPLC/DAD
  1187. Simultaneous determination of liquiritin, hesperidin, and Glycyrrhizin by HPLC-photodiode array detection and the anti-inflammatory effect of Pyungwi-san
  1188. Simultaneous Determination of Paeoniflorin and Glycyrrhizin in Sayuk-san by HPLC/DAD
  1189. Simultaneous determination of paeoniflorin, trans-cinnamic acid, schisandrin and Glycyrrhizin in So-Cheong-Ryong-Tang by HPLC-DAD and HPLC-ESI-MS
  1190. Simultaneous Determination of Paeoniflorin, trans-cinnamic acid, Schisandrin and Glycyrrhizin in So-Cheong-Ryong-Tang by HPLC-DAD and HPLC-ESI-MS
  1191. Simultaneous estimation of Glycyrrhizin and Catechin from marketed herbal formulations by hptlc
  1192. Simultaneous HPLC analysis, with isocratic elution, of Glycyrrhizin and glycyrrhetic acid in liquorice roots and confectionery products
  1193. Solid‐phase extraction of liquiritin and Glycyrrhizin from licorice using porous alkyl‐pyridinium polymer sorbent
  1194. Solubility and Apparent Oil/Water Partition Coefficient of Glycyrrhizin and Pachymic Acid [J]
  1195. Solubility of Glycyrrhizin in supercritical carbon dioxide with and without cosolvent
  1196. Solubilizing properties of Glycyrrhizin and its derivatives: solubilization of saikosaponin-a, the saponin of bupleuri radix
  1197. Some haematological and biochemical investigations on duck virus hepatitis following administration of Glycyrrhizin
  1198. Some pharmacologic actions of Glycyrrhizin in mice
  1199. Special Licorice Extracts Containing Lowered Glycyrrhizin and Enhanced Licochalcone A Prevented Helicobacter pylori‐Initiated, Salt Diet‐Promoted Gastric …
  1200. Spectral quality and UV-B stress stimulate Glycyrrhizin concentration of Glycyrrhiza uralensis in hydroponic and pot system
  1201. Spectroscopic and molecular dynamics characterization of Glycyrrhizin membrane-modifying activity
  1202. Stimulation of host resistance against tumors by Glycyrrhizin, an active component of licorice roots.
  1203. Stimulation of melanogenesis by Glycyrrhizin in B16 melanoma cells
  1204. Stimulation of rat adrenocortical cells by Glycyrrhizin with special reference to its inhibitory effect on dexamethasone-induced atrophy of the adrenal cortex
  1205. Stricter control of alanine transaminase by long-term administration of Glycyrrhizin counters the disease progression in patients with chronic hepatitis C
  1206. Stronger Neo‐Minophagen C™, a Glycyrrhizin‐containing preparation, protects liver against carbon tetrachloride‐induced oxidative stress in transgenic mice …
  1207. Studies of the determination of Glycyrrhizin acid kali salt by HPLC and the pharmacokinetics
  1208. Studies of the Determination of Glycyrrhizin Acid Kali Salt by HPLC and the Pharmacokinetics [J]
  1209. Studies on concentration of Glycyrrhizin in plasma and its absorption after oral administration of licorice extract and Glycyrrhizin
  1210. Studies on curative effects of Glycyrrhizin treating chronic active hepatitis and action of Glycyrrhizin on regulating body immune
  1211. Studies on Differentiation and Apoptosis of Human Hepatocarcinoma Cells Induced by All-trans Retinoic Acid, 18p-glycyrrhetinic Acid and Glycyrrhizin
  1212. Studies on mechanism of action of Glycyrrhizin against hepatitis A virus replication in vitro
  1213. STUDIES ON PROLIFERATION INHIBITION AND ANTI-INVASION OF Glycyrrhizin IN HIGHLYMETASTASIS HUMAN LUNG CANCER CELL LINE
  1214. Studies on the enzyme immunoassay of bio-active constituents contained in oriental medicinal drugs. II. Enzyme immunoassay of Glycyrrhizin
  1215. Studies on the processing of crude drugs (IV)-Physico-chemical transformation of Glycyrrhizin in Glycyrrhizae Radix by processing
  1216. Study of antiparasitic effects of Ginger and Glycyrrhizin aqua extracts against Neospora caninum
  1217. Study of protective effects of Glycyrrhizin in lithium chloride induced Nephrogenic Diabetes Insipidus in rats
  1218. Study of selective hydrolysis of Glycyrrhizin and the molecular complex of Glycyrrhizin and sialic acid
  1219. Study of the Binding of Glycyrrhizin to Albumin
  1220. Study of the stability of compound Glycyrrhizin tablets [J]
  1221. Study on antipyretic action of dipseudoephedrine Glycyrrhizin and its effect on heart rate and blood pressure of rats
  1222. Study on bacterial endotoxin test for Compound Glycyrrhizin for Injection [J]
  1223. Study on bacterial endotoxins test for compound Glycyrrhizin for injection [J]
  1224. Study on biotransformation of Glycyrrhizin
  1225. Study on clinical and immunological effects of compound Glycyrrhizin on oral lichen planus patients
  1226. Study on Intervention of Glycyrrhizin and Dexamethasone on Podocytes Injury Induced by Puromycin Aminonucleoside in vitro
  1227. Study on relationship between Glycyrrhizin-induced apoptosis and intracellular Ca~(2+) concentration in human breast carcinoma cells [J]
  1228. Study on the Content of Glycyrrhizin, 18-glycyrrhetinic acid and glycyrrhizic ammonium salt in Glycyrrhizae Radix(Glycyrrhiza sp.) Used in Korea
  1229. Study on the expression of nuclear factor-κB in nephridial tissue and the protective role of Glycyrrhizin on adriamycin nephropathy in rats
  1230. Study on the formulation and preparation technique of Compound Glycyrrhizin Tablet [J]
  1231. Study on the interaction of Glycyrrhizin and glycyrrhetinic acid with RNA
  1232. Study on the regulatory effect of Glycyrrhizin on transforming growth facor? signaling pathway of hepatic stellate cell in mice by cDNA microarray
  1233. Supercritical carbon dioxide extraction of Glycyrrhizin from licorice root
  1234. Suppression of porcine reproductive and respiratory syndrome virus proliferation by Glycyrrhizin
  1235. Suppressive effect of Glycyrrhizin on murine contact hypersensitivity
  1236. Synergistic effect of cadmium chloride and acetaldehyde on cytotoxicity and its prevention by quercetin and Glycyrrhizin
  1237. Synthesis and antiviral activities of spacer-linked 1-thioglucuronide analogues of Glycyrrhizin
  1238. Synthesis and characterization of Glycyrrhizin-decorated graphene oxide for hepatocyte-targeted delivery
  1239. Synthesis and HK-2 Cellular Uptake of Low Molecular Weight Chitosan Glycyrrhizin Conjugate
  1240. Synthesis and separation of 18β-glycyrrhetyl monoglucuronide from serum of a patient with Glycyrrhizin-induced pseudo-aldosteronism
  1241. Synthesis of Glycyrrhizin analogues containing fluorinated β (1→ 2)-linked disaccharides
  1242. Synthesis of Type IV Collagen and Laminin during Proliferation and Differentiation of 3T3-L1 Cells by Glycyrrhizin
  1243. Synthesis, biological evaluation, and molecular modeling of Glycyrrhizin derivatives as potent high-mobility group box-1 inhibitors with anti-heart-failure activity in vivo
  1244. Synthesis, molecular docking and biological evaluation of Glycyrrhizin analogs as anticancer agents targeting EGFR
  1245. Targeting Binding of Chitosan Nanoparticles with Glycyrrhizin Surface Modification to Hepatic Parenchymal Cells in Vitro [J]
  1246. Targeting of Liposomes Surface-Modified with Glycyrrhizin to the Liver. I. cal Disposition
  1247. Targeting of liposomes surface-modified with Glycyrrhizin to the liver. I. Preparation and biological disoposition.
  1248. Targeting of liposomes surface-modified with Glycyrrhizin to the liver. I. Preparation and biological disposition
  1249. Tests for mutagenic effects of ammoniated Glycyrrhizin, butylated hydroxytoluene, and gum Arabic in rodent germ cells
  1250. The analysis of efficacy of Glycyrrhizin therapy for autoimmune hepatitis [J]
  1251. The anti-inflammatory and anti-viral effects of an ethnic medicine: Glycyrrhizin
  1252. The anticariogenic activity of Glycyrrhizin: preliminary clinical trials.
  1253. The biological significance of Glycyrrhizin-and glycyrrhetinic acid derivative-induced selective phosphorylation of histones H2A and H2B by A-kinase in vitro
  1254. The blood–brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of Glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine …
  1255. The broad anti-viral agent Glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope
  1256. The Clinical effect of compound Glycyrrhizin on tuberculosis [J]
  1257. The clinical efficacy and safety of oral compound Glycyrrhizin in adult patients with mild-to-moderate active alopecia areata: A randomized controlled study
  1258. The clinical observation of compound Glycyrrhizin in patients with allergic purpura [J]
  1259. THE CLINICAL OBSERVATION OF THE EFFECTS OF COMPOUND Glycyrrhizin IN TREATING HEPATITIS CAUSED BY ANTI-TUBERCULOSIS DRUGS
  1260. The clinical observation on Compound Flumetasone Ointment and Compound Glycyrrhizin for children eczema
  1261. The clinical observation on the therapeutic effect of compound Glycyrrhizin combined with reduced glutathione in the treatment of chemotherapy-induced liver injury [J]
  1262. The combination of Glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance …
  1263. The comparative effects of nano and bulk size particles of CuO and ZnO on Glycyrrhizin and phenolic compounds contents in Glycyrrhiza glabra L. seedlings
  1264. The curative effect of adefovir dipivoxil combined with compound Glycyrrhizin for chronic hepatitis B
  1265. The Curative Effect of Telbivudine Combined with Compound Glycyrrhizin for Chronic Hepatitis B
  1266. The determination of Glycyrrhizin in selected UK liquorice products
  1267. The difference between cholesterol-and Glycyrrhizin-γ-cyclodextrin complexes—an analysis by MD simulations in vacuo and in aquo and the calculation of solvation …
  1268. The dramatic effect of intravenous Glycyrrhizin on acute‐on‐chronic hepatic failure in chronic hepatitis B patients without liver cirrhosis
  1269. The effect of complex Glycyrrhizin on the keratinocytes cultured in vitro
  1270. The Effect of Compound Glycyrrhizin Combined with Antihistamines on Chronic Urticaria [J]
  1271. The effect of Glycyrrhizin on maturation and T cell stimulating activity of dendritic cells
  1272. The effect of Glycyrrhizin on rainbow trout, Oncorhynchus mykiss (Walbaum), leucocyte responses
  1273. The effect of Glycyrrhizin on the release rate and skin penetration of diclofenac sodium from topical formulations
  1274. The effect of topical 0.1% tacrolimus ointment and compound Glycyrrhizin on facial corticosteroid dependent dermatitis
  1275. The Effective Analysis of NB-UVB with Compound Glycyrrhizin in the Treatment of Pityriasis Rosea
  1276. The effects and mechanisms of Glycyrrhizin on the TNBS-induced pancreatic fibrosis in rat
  1277. The effects of 18β-glycyrrhetinic acid and Glycyrrhizin on intestinal absorption of paeoniflorin using the everted rat gut sac model
  1278. The effects of compound Glycyrrhizin liposome on proliferation of human hepatic stellate cells
  1279. The effects of digitonin and Glycyrrhizin on liposomes
  1280. The effects of Glycyrrhizin on acute pancreatitis in mice
  1281. THE EFFECTS OF Glycyrrhizin ON cAMP AND PGE_2 CONTENTS OF RAT MACROPHAGES AND SOME IMMUNOLOGICAL FUNCTIONS
  1282. The effects of Glycyrrhizin-18alpha on the expression of NF-kappaB in the renal interstitium of rats with obstructive nephropathy
  1283. The effects of pretreatment with Glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats
  1284. The Extract of the Glycyrrhizin from Glycyrrhizae Radix and Antibacterial Activity of the Treated Fabrics
  1285. The in vitro Antiviral Mechanisms of Stronger Neo-Minophafen C, an Established Formulation of Compound Glycyrrhizin
  1286. The in vitro effects of Glycyrrhizin and the derivatives of glycyrrhetinic acid on the activity of cAMP-dependent protein kinase and phosphorylation of cellular …
  1287. The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of Glycyrrhizin from Shaoyao-Gancao-tang
  1288. The influence of compound Glycyrrhizin on expression of HMB45, TNF-? and IL-6 in lesion of vitiligo guinea pig model
  1289. The influence of compound Glycyrrhizin on expression of HMB45, TNF-α and IL-6 in lesion of vitiligo guinea pig model.
  1290. The influence of the exogenous calcium on the accumulation of Glycyrrhizin in the cultivated Glycyrrhiza uralensis Fisch
  1291. The inhibiory effect of Glycyrrhizin and flavonoids on the reductive metabolism of glucocorticoid by the rat cecal contents.
  1292. The inhibiting effect of Glycyrrhizin on proliferation of the mice submandibular gland fibrosarcoma cell line in vitro
  1293. The inhibition of apoptosis by Glycyrrhizin in hepatic injury induced by injection of lipopolysaccharide/D-galactosamine in mice
  1294. The inhibitory effects of Glycyrrhizin and glycyrrhetinic acid on the metabolism of cortisol and prednisolone–in vivo and in vitro studies
  1295. The long term efficacy of Glycyrrhizin in chronic hepatitis C patients
  1296. The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by Glycyrrhizin in hepatocellular carcinoma
  1297. The Near Clinical Study of Compound Glycyrrhizin on Treating 50 Eczema Patients [J]
  1298. The oral pretreatment of Glycyrrhizin prevents surgery-induced cognitive impairment in aged mice by reducing neuroinflammation and Alzheimer’s-related pathology …
  1299. THE PERCENT OF EXTRACT AND Glycyrrhizin CONTENT OF GLYCYRRHIA GLABRA ROOT GROWN IN KERMAN PROVINCE AND SOME SAMPLES FROM …
  1300. The pharmacokinetics of Glycyrrhizin and its restorative effect on hepatic function in patients with chronic hepatitis and in chronically carbon‐tetrachloride‐intoxicated …
  1301. The pharmacokinetics of the Glycyrrhizin and glycyrrhetic acid after intravenous administration of Glycyrrhizin for the patients with chronic liver disease caused by type …
  1302. The Plaque Psoriasis of Acitretin A Combined Glycyrrhizin to Plaque Psoriasis [J]
  1303. The preventive and therapeutic actions of Glycyrrhizin, Glycyrrhetic acid and crude saikosides on experimental cirrhosis in rats
  1304. THE PROLIFERATION INHIBITION AND DIFFERENTIATION INDUCTION OF 18β-GLYCYRRHETINIC ACID AND Glycyrrhizin ON BEL-7402 HUMAN …
  1305. The protective effect of Glycyrrhizin against injury of the liver caused by ischemia-reperfusion
  1306. The protective effect of Glycyrrhizin on anti-Fas antibody-induced hepatitis in mice
  1307. The protective effects of MPLC isolated Glycyrrhizin and mangiferin against brain toxicity in rats
  1308. The relationship between pharmacokinetic behaviour of Glycyrrhizin and hepatic function in patients with acute hepatitis and liver cirrhosis
  1309. The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy
  1310. The selective effect of Glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB …
  1311. The simulation on self-aggregated Glycyrrhizin structures
  1312. The stimulatory and inhibitory effects of Glycyrrhizin and a glycyrrhetinic acid derivative on phosphorylation of lipocortin I by A-kinase in vitro.
  1313. The structure activity relationship of saikosaponins and Glycyrrhizin derivatives for Na+, K (+)-ATPase inhibiting action
  1314. The Stuty of the Influence of Glycyrrhizin to T-Lymphocyte-subsetes, Interleukin in the Patients with Chronic Hepatitis B
  1315. The synergistic anti-asthmatic effects of Glycyrrhizin and salbutamol
  1316. The Technology of Microwave-assisted Extraction of Glycyrrhizin [J]
  1317. The Technology of the Purification of Glycyrrhizin with Macroporous Resin [J]
  1318. The treatment of eczema with combination of traditional Chinese medicine with compound Glycyrrhizin injection
  1319. The use of Stronger Neo-Minophagen C, a Glycyrrhizin-containing preparation, in robust neuroprotection in the postischemic brain
  1320. The Vitro Study on Intervention of Glycyrrhizin and Dexamethasone in Podocytes Proliferation
  1321. Therapeutic basis of Glycyrrhizin on chronic hepatitis B
  1322. Therapeutic Effect Observation on Chronic Hepatitis B Treated with Compound Glycyrrhizin Plus Urˉsodeoxycholic Acid [J]
  1323. Therapeutic Effect of Arbutin Combined with Glycyrrhizin on Immune-inflammation
  1324. Therapeutic effect of combined triptolide and Glycyrrhizin treatment on rats with collagen induced arthritis
  1325. Therapeutic Effect of Compound Glycyrrhizin and Reductive Glutathione on the Hepatitis Suffered From Drugs
  1326. Therapeutic effect of compound Glycyrrhizin combined with narrow-spectrum UVB on eczema
  1327. Therapeutic effect of compound Glycyrrhizin in active ulcerative colitis
  1328. Therapeutic Effect of Compound Glycyrrhizin in the Treatment of Acute Urticaria
  1329. Therapeutic Effect of Compound Glycyrrhizin on Hepatic Fibrosis of Patients with Chronic Hepatitis B [J]
  1330. Therapeutic effect of desloratadine plus compoud Glycyrrhizin in treatment of chronic urticaria
  1331. Therapeutic Effect of Glycyrrhizin Arginine Salt on Rat Cholestatic Cirrhosis and its Mechanism
  1332. Therapeutic effect of Glycyrrhizin for severe acute pancreatitis in rats [J]
  1333. Therapeutic effect of Glycyrrhizin with Ursodeoxycholic acid on patients with non-alcoholic steatohepatitis
  1334. Therapeutic Effect of IF_ (α-2b) Plus Compound Glycyrrhizin on Chronic Hepatitis C [J]
  1335. Therapeutic effect of narrow-spectrum UVB combined with compound Glycyrrhizin on chronic eczema
  1336. Therapeutic effect of narrow-spectrum UVB combined with compound Glycyrrhizin on chronic eczema
  1337. Therapeutic Effects of Compound Glycyrrhizin and Ganlixin on Relapse Following Withdrawal of Lamivudine
  1338. Therapeutic effects of compound Glycyrrhizin combined with reduced glutathione on patients with alcoholic liver disease
  1339. Therapeutic effects of compound Glycyrrhizin liposome on fibrosis of the rats with nonalcoholic steatohepatitis.
  1340. Therapeutic effects of compound Glycyrrhizin liposome on rats with nonalcoholic steatohepatitis.[J]
  1341. Therapeutic Effects of Compound Glycyrrhizin on Patients with Hepatitis Induced by Anti-tuberculosis Drugs
  1342. Therapeutic effects of Glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression
  1343. Therapeutic Efficacy Observation of Famciclovir Combined with Compound Glycyrrhizin for Recurrent Genital Herpes
  1344. Therapeutic Efficacy of Reduced Glutathione Plus Compound Glycyrrhizin for Pathological Jaundice of Newborn
  1345. Therapeutic observation of compound Glycyrrhizin combined with epinastine in the treatment of chronic eczema
  1346. Therapeutic observation on compound Glycyrrhizin for medicamentous liver lesion induced by chemotherapy
  1347. Theraputic effect of Glycyrrhizin on herpes simplex encephalitis
  1348. Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with Glycyrrhizin or ursodeoxycholic acid
  1349. Topical application of Glycyrrhizin preparation ameliorates experimentally induced colitis in rats
  1350. Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis
  1351. Total glucosides of paeony capsule plus compound Glycyrrhizin tablets for the treatment of severe alopecia areata in children: a randomized controlled trial
  1352. Transdermal delivery of carvedilol containing Glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic …
  1353. Treating acute eczema with compound Glycyrrhizin: a report of 68 cases
  1354. Treatment efficacy of liver damage caused by antituberculosis drugs with compound Glycyrrhizin and reduced glutathione
  1355. Treatment of alopecia areata with compound Glycyrrhizin and topical minoxidil [J]
  1356. Treatment of compound Glycyrrhizin tablets on nonalcoholic steatohepatitis
  1357. Treatment of epidemic encephalitis B with Glycyrrhizin in 38 children
  1358. Treatment of facial corticosteroid addicive dermatitis with compound Glycyrrhizin and collagen dressing [J]
  1359. Treatment of psoriasis by compound Glycyrrhizin injection and its effects on peripheral blood Th17 cell proportion and IL-22 concentration
  1360. Treatment of Psoriatic Erythroderma with Acitretin, Compound Glycyrrhizin Injection and Dermatitis Decoction
  1361. Treatment of subacute hepatitis with lamivudine and intravenous Glycyrrhizin: a pilot study
  1362. Triterpene functional genomics in licorice for identification of CYP72A154 involved in the biosynthesis of Glycyrrhizin
  1363. Tuning the pH profile of β-glucuronidase by rational site-directed mutagenesis for efficient transformation of Glycyrrhizin
  1364. Unequivocal Glycyrrhizin isomer determination and comparative in vitro bioactivities of root extracts in four Glycyrrhiza species
  1365. Unique coordination mode of potassium ions to Glycyrrhizin: X-ray crystal structure of Glycyrrhizin dipotassium salt
  1366. UP-2.074: Protective Effect of Glycyrrhizin on Nephrotic Syndrome Induced By Adriamycin in Rats
  1367. Upregulation effect of Glycyrrhizin on secretory component expression in Caco-2 cells
  1368. Uptake of albumin nanoparticle surface modified with Glycyrrhizin by primary cultured rat hepatocytes
  1369. Uptake of Glycyrrhizin by isolated rat hepatocytes
  1370. Uptake of liposomes surface-modified with Glycyrrhizin by primary cultured rat hepatocytes
  1371. Uptake of Liposomes Surface-Modified with Glycyrrhizin by Primary Cultured Rat Hepatocytes
  1372. Urinary steroid excretion after total adrenalectomy. I. Levels of 17-ketosteroids in cancer patients maintained on varying amounts of cortisone acetate and Glycyrrhizin
  1373. Ursodeoxycholic acid decreases the serum transaminase levels of chronic liver disease patients treated with Glycyrrhizin
  1374. Use of Glycyrrhizin after bilateral adrenalectomy
  1375. Use of Glycyrrhizin in prevention of tissue damage caused by ischemia-reperfusion in rabbit hind limbs
  1376. Use of nano‐liquid chromatography for the analysis of Glycyrrhizin and glycyrrhetic acid in licorice roots and candies
  1377. Using LC/MS/MS to determine matrine, oxymatrine, ferulic acid, mangiferin, and Glycyrrhizin in the Chinese medicinal preparations Shiau-feng-saan and Dang-guei …
  1378. Utility of a little phlebotomy intermittently just before intravenous injection of Glycyrrhizin for patients with chronic hepatitis C
  1379. Utility of nano-sized, water-in-oil emulsion as a sustained release formulation of Glycyrrhizin
  1380. Utilization of Glycyrrhizin and Licorice Extract as Natural Sweetener in Some Food Products and Biological Impacts
  1381. Variation of Glycyrrhizin and liquiritin contents within a population of 5-year-old licorice (Glycyrrhiza uralensis) plants cultivated under the same conditions
  1382. Western blotting method for the immunostaining detection of glucuronides of glycyrrhetic acid using anti-Glycyrrhizin monoclonal antibody
  1383. Western blotting of glycyrrhetinic acid glucuronides using anti-Glycyrrhizin monoclonal antibody
Related Posts

Sophorae Fructus

Phloroglucinol

Wolfiporia Extensa

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping